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ABSTRACT
Saudi Arabia, one of the developing countries, has a
number of problems with the health care and medical treatment of the Saudi people. This study was undertaken to
identify and to examine some of these problems and the role
of the pharmacist in health education.
A questionnaire was developed and sent to 200 Saudi
-----~~-----s-t--u.-deiTt-s--±-rT--tlTe-Urrrt-e-a---st-a

t-es-; -11-1--- c-omp-l-ete-d qu-est-ionnaires ----------- ----

were returned. The questionnaire was also sent to Saudi
Arabia where 51 persons were interviewed. Results of the
questionnaire indicated that some of the problems identified
were due to the attitudes of the person interviewed and others
resulted from the quality of pharmaceutical services which
were provided. Some patients in Saudi Arabia want a "cure"
from the first contact with the physician; some do not want
to use the medications for a long period of time, for example,
those who are undergoing treatment for chronic diseases.
Some go to more than one physician and may receive prescriptions for two or more drugs. Others may discontinue
the drug and not return to the physician. Some may obtain
their medications without a prescription and others may
use the medication(s) prescribed for other persons. Generally, it was determined that the services provided by the
pharmacist were not what the patient expected and wanted.
Also poor communication between the patient and the pharmacist was identified. Language problems were the usual
cause cited.
These problems may lead to treatment failure and/or
an increase in the incidence of adverse drug reactions or
drug-drug interactions.
Recommendations were developed in an attempt to alleviate some of these problems. These recommendations include
the requirement that each hospital keep a medical record
for each patient, and also that a medication record for each
patient be kept in the pharmacy to avoid the duplication o
medications (prescriptions).
The law or regulations which
restricts the availability of medicines without a prescription from any pharmacy inside the hospitals or from market
pharmacies should be adhered to and enforced by the
pharmacists.

-

,,

Appointments for outpatients should be made to reduce
the crowds of people at the doctor's office or at the pharmacy
windows. This will encourage good communication and allow more
time for the physician, pharmacist and the patient to discuss
the disease and treatment. To overcome poor communications
due to the language barrier, it is important that only those
physicians and pharmacists who can speak the Arabic language
work in the outpatient departments.
Encouragement of patient participation in his treatment
can be provided by enhancing health education in the media
such as in newspapers and on radio and television programs.
The pharmacist should play a role in solving these problems
b-Y-mG n-i- tG-r-i-n-g--<1-Fu-g-t-h-er-a-py--.-- --------- -------

The appendix contains a proposal which specifies the
types of information which should be provided to Saudi
patients regarding their prescribed medications. The
diseases included in the appendix were selected as examples
because they are rather common in Saudi Arabia.
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CHAPTER I
INTRODUCTION
Saudi Arabia has an area of approximately 2,000,000 km
and has a population of approximately 7,600,000.

2

There are

89 hospitals which have 12,000 beds, 299 outpatient health
centers which are run by physicians and 383 dispensaries
which are run by auxiliaries.

There are approximately

4700 physicians,8% of whom are Saudi and 6400 nurses, 14%
of whom are Saudi (1).
Saudi Arabia has specialized hospitals which have soph~sticated

equipment and well trained staff.

in these hospitals are excellent.

The services

They are controlled by

different departments of the government, such, as the Ministry
of Health, Defense, Interior, the National Guard, and the
University (2).

There are three types of services avail-

able especially in villages and rural areas.

The first

type: which is called Type A, has two physicians and several
nurses and unskilled personnel.

The second is Type B which

has one physician and one nurse, and the third is Type C
(Health Point) which is staffed by a nurse or a pharmacist
assistant and one servant.

All hospitals have large

outpatient departments (2).
1
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A weekly television program, called "Medicine and
Life" is run on five stations in Saudi Arabia (3).

It re-

quests the viewers to send letters asking about health problems which the program could explain or upon which they could
give advice.

Five thousand two hundred forty letters were

received during the past five years and 786 randomly selected letters were analyzed.

Six hundred four letters asked

s-pec-i-f-i-c-a-1-1-~,...-a-bo-u-t-t-he-w"ri-t-ers-'-

own---i-l-l-nesses-;---- --T-he--ma-j-or

problems that the viewers mentioned in the letters are
listed in Table 1.

Another report (4) included a list of

primary care problems, and involved' the first 166 patients
who attended the outpatient clinic in the Riyadh Military
Hospital (between 9 October and 20 October, 1978).

The

166 patients presented, had 240 medical problems (incidence
1.4 problems per patient) and Table 2 lists the problems in
descending order of incidence.
Saudi Arabia, one of the developing countries, has
problems concerning health care and treatment of diseases.
These problems can be summarized as follows:

Many patients

want a cure from the first contact with the physician; some
do not want to use the medications for a long period of
time; the patient may change his doctor and may receive two
prescriptions; and the patient may stop or discontinue his
medications without returning to the doctor.

The person may

use medications obtained from friends or relatives, or may
go directly to the pharmacy to get his medications without
a prescription and without realizing the potential hazards

3

Table 1.

The 15 Main Health Problems Mentioned by
Correspondents to the Television Program
(Medicine and Life) (3).
Male

Female

Total

22

13

35

6

4

10

31

21

52

15

9

24

32

14

46

28

19

47

6

10

16

Disease of digestive system

41

23

64

Disease of

28

12

40

13

40

53

11

11

Problems
Infective and parasitic diseases
Neoplasm
Endocrine, nutritional and
Metabolic diseases
~---

-B±sease-crf-th-e--rnooa-arm-orooaforming organs
Mental disorders
I

Disease of nervous system
Disease of circulatory system

~espiratory

system

Disease of genito-urinary
system
Complications of pregnancy
Disease of niusculo-skeletal
and connective tissue

15

12

27

Disease of skin

19

45

64

Congenital anomalies

7

5

12

Accident and

5

2

7

~oisoning

4

Table 2.

Occurrence of 240 Medical Problems in 166 Patients
seen at the Out Patient Department, Riyadh
Military Hospital (4).

Problem

No. of Problems

Percentage

Gastrointestinal

51

21.3

Cardiovascular

49

20.4

Dermatological

33

13.8

----~---Re_sp_ir_at_o_r_y,___ --------~---------29________________

12_._1_____

Genito-urinary

19

7.9

Neuropsychiatric

18

7.5

Musculo-skeletal

14

5.8

Endocrine

10

4.2

Obstetric

8

3.3

Iatrogenic

5

2.1

General debility

4

1. 7.

_ ______ _

0

of self medication.

Communication between the physician

and the patient is frequently inadequate, and communication between the pharmacist and the patient is usually
poor.
In Saudi Arabia, the patient frequently goes from one
clinic 'to another and from one physician to another.

Patients

can buy non-narcotic analgesics and tranquilizers without
-------a-presc!'-ip-tion_, _ __

The Dean of the School of Pharmacy at the University
of Riyadh has stated:
" ... like many other developing countries, several
factors contributed to the less than optimal use
of drugs in Saudi Arabia.

Some of these contrib-

uting factors were unawareness among the public
about the danger involved in self medication, poor
patient compliance, the availability of most of
the non-narcotic drugs without a prescription, a
lack of adequate drug information, poor physicianpatient-pharmacist communication, and the promotional activities of drug companies." (5)
A study was conducted by Dr. Al Sebai (1) of three
health centers in rural areas of Saudi Arabia.

These centers

did not differ from those in other parts of the country,
especially the out-clinic patient departments of general
public hospitals.

This study showed that the physician

spent approximately three minutes with the patient due to

6

the large number of people and lack of physicians.

This

time did not allow the physician the opportunity to diagnose
or to treat the condition properly.

This study also showed

that diagnosis was based upon clinical impressions without
any diagnostic facilities.
pensed indiscriminately.

Medications were sometimes disSixteen patients were interviewed

after they had been discharged from the outpatient department.

ness, and only five patients of the sixteen knew how to
use the medication prescribed for them.

This study showed

that 30% of all prescriptions were for antibiotics and 18%
of these antibiotics were chloramphenicol.·
chloramphenicol were given to the children.

Injections of
Twenty-four per-

cent of the prescriptions were antipyretics and analgesics.
The author concluded that antibiotics were used indiscriminately.

For example, patients may receive one injection

of an antibiotic and then enough oral doses for three days
of treatment, which he o.r she may not use.

From the above,

it was clear that the patients in these centers failed to
absorb the information which was given to them.

The study

concluded that these centers did not perform their function in
an adequate manner due to several factors or reasons.

The

reasons given were (1) lack of physicians' understanding
of their role, (2) shortage and inappropriate distribution of Saudi physicians, and (3) inadequate planning,

7

supervision, and follow-up of the function.

This study

concluded that the main problem was the lack of health
education in the people served, which resulted in poor
community participation.
The patient in Saudi Arabia needs more information
about health matters and more effort and time must be spent
in health education.

In studies comparing the primary

e-a-r-e-s-:>t-s-t-em-(-f-i-P-s-t-een-t-a-e-t-)---a-n d--f-i-r-s-t- -1-e v-el -p-r i-ma-X-J --G a!!-e-,
1

Dodd (6) presented several illustrative cases.

The cases

demonstrated some patients' reactions to and opinions of
their problems.
Case I:
"A middle-aged Sergeant in the Army who had burning epigastric pain for fifteen years.

The pain

interferes with his life and makes him miserable;
it has been investigated with several barium meals
and much treated.

He says that it is brought on by

eating large, fatty meals or hot spicy food and that
it is not too bad when he takes antacid.

When it

was suggested that he might avoid his pain by modifying his diet, he rejected it because he did not want
always to be taking medicine.

He just wanted a

straight-forward, once and for all cure of his pain."
Case II:
"A Captain in the Air Force, both he and his wife
have had asthma for four years.

About three years

8

ago he was given, by a doctor in the town, Betametha~one

tablets, which produced a very remarkable cure.

He continued to buy them in the market even after they
had lost their anti-asthmatic effect and made him obese,
hypertensive, and cushingoid.

He was sent to London

where his asthma was controlled and he was weaned off
his steroids.

He came home feeling much better and in

f--ae-t----,-----Se-l-:i:-e-ve€1.--t-ha t-he vvas cured-.- -He --was --ver-y- u-pset--w-hen-------------

the asthma recurred six months later.

He came to the

clinic to see if we could cure him."
Case III:
"A man aged about 60, who has had diabetes for about
four years.
tions.

At present there is no sign of complica-

His principle symptoms are polyuria and occa-

sional burning micturition.

He has attended two pri-

vate doctors in the town, each of whom has prescribed
a different hypoglycemic agent.

According to his

symptoms each day he takes one or the other, both or
none of his tablets."
These cases indicate that patients have a poor knowledge of their diseases.

From the above cases one can under-

stand the feelings and reactions of uneducated patients
about their diseases and treatments.
1.

The patient does not realize the danger of the

9

illness or disorder, unless it is very severe and leads'to
hospitalization.
2.

The patient wants a cure from the first contact

with the physician.

He thinks that just one visit is suf-

ficient.
3.

The patient does not want to use the medications

for long periods of time in chronic disease states;.
-4-.-He-G-r-s-h-e-de e s-ne-t---r-eco g-n-i ze -t-h-e-- Bene f-i-t-s--- a-nd

·limitations of the medications.
5.

The patient may discontinue his medications sud-

denly without returning to the physician.
6.

He does not realize the dangers of medication.

He may misuse or abuse these medications and experience dangerous adverse drug reactions.
7.

The patient may go to more than one physician for

the same illness and receive different prescriptions.

He

may use both of these prescriptions or just one or none of
them.
Another study (7) was done in a Riyadh
of 10 women between age 21-32 years.
they did not attend antenatal clinics.

~ilitary

hospital

They were asked why
The reasons given

for the failure of the women to participate included:

fear

of the doctor; they did not know what the clinic was for;
or they were feeling well and did not need to visit the
clinic.

When they were asked about the importance of

attending the antenatal clinic, all the responses were
"we do not understand the importance of these clinics."

10

Five thousand two hundred and forty letters were received in the television program (3) and 786 randomly selected letters were analyzed.

Sixty-one percent of the cor-

respondents were male ranging in age from 15 to 25 years.
Six hundred four letters asked specifically about the correspondents' own illness.

One hundred forty-six letters

out of 786 asked about general health problems.

Two hund-

red forty letters which were received included questions
about a specific treatment for the correspondents' complaints.
Three hundred sixty letters mentioned the fact that the writer
had already sought medical advice.

One hundred thirty-two

of the 786 mentioned that they had been seen by more than
one physician.

Thirty-two letters explained that they had

visited a traditional healer who practiced

Arabic medicine.

This study concluded that consulting more than one physician
at the same time is a common practice, and the majority who
wrote these letters were young people interested in their .
own health.

The author recommended further health education

programs and the introduction ·of these programs into the
schools (3).
The pharmacist can have an active role in improving the
health care in Saudi Arabia.

He can be a source of informa-

tion regarding the appropriate use of medications, and the
pharmacist could provide educational services for the outpatient such as:

11
1.

The importance of taking medicine as directed.

2.

Appropriate dosage schedule.

3.

Determination of drug(s) already being taken by
the patient which might interfere with any newly
prescribed medications.

4.

What drugs, food, or over-the-counter medications
to avoid while on the newly prescribed therapy (8).

---Th-e-r-e-aX-e-s-e-V-e-!!-a-1--f-u-n-G!-t-i 0n s---l.:v-h-i ch the- pha-rmacists can
perform such as:
1.

Obtaining and maintaining a patient data base for
use in making pharmaceutical decisions affecting
patient care.

2.

Adivising the patient on OTC drug therapy.

3.

Consulting with physicians about therapeutic
goals and end points, appropriate drug therapy,
and product selection.

4.

Consulting with patients about the proper use of
prescription medications.

5.

Referring the patient to appropriate health care
personnel on the basis of problem assessment.

6.

Safely dispensing, distributing, and administering medications to patients.

7.

Identifying manifestations of any drug toxicities
and taking appropriate action.

8.

Serving as a source of health and drug information
for the patient. (9)
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The pharmacist may play a role and influence the selection of over-the-counter (OTC) medications, and the advice
concerning the appropriate use of OTC medication is the
responsibility of the P.harmacist.

The pharmacist should

give an accurate therapeutic consultation (10).
Statement of Purposes
'T'he_pur_pose_of_this--S-tudy-was--to-determine_the_t¥-Pes _____

of and the level of information which should be provided
to Saudi patients about their prescribed medications, and
to identify problems concerning the patient's use of
medications prescribed by outpatient departments.

A ques-

tionnaire was designed to elicit the above information.
This thesis analyzed the

resul~obtained

from the question-

naire, and from this information makes recommendations regarding the role of the pharmacist in health education in
Saudi Arabia.

To address the information deficiencies

identified in the survey, an appendix was prepared which
includes examples of some diseases which are common in Saudi
Arabia.

Included for each disease is a description of the

disease and possible causes, drug treatment, instruction to
the pharmacist and instruction to be given to the patient
regarding the medications.

CHAPTER II
METHODOLOGY
A questionnaire (Figure 1) was developed, and sent to
various cities in different parts of the United States.
The cities were Stockton, Chico, Redwood City, and
Sacramento, California; Portland, Oregon; and Washington,
D.C.

These cities were selected because they have a rela-

tively large population of Saudi students.

The majority

of these students are males living temporarily in the
United States.

When they finish their studies, it is

anticipated that they will return home.
was developed

A questionnaire

and sent to 200 Saudi students in the United

States; 111 completed questionnaires were returned.
three students were male and 18 were female.

Ninety-

The distribu-

tion of the students who completed the questionnaire was
as follows:

Redwood City, 16; Chico, 16; Sacramento, 16;

Portland, Oregon, 25; Washington, D.C., 20; and Stockton,
CA, 18.

These students represented different parts of

Saudi Arabia which included all of the five regional divisions,

West~

East, North, South, and the Middle.

The format of the questionnaire is presented in Figure
1.

It was requested that these questions be answered as
13
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to the respondents' behavior and experience in Saudi Arabia
and not their experience in the United States.

The quesion-

naire shown in Figure 1 was also sent for administration
in Riyadh, Saudi Arabia in order to get responses for comparison with the answers given in the United States.

Fifty-

one persons (44 males, 7 females) completed the questionnaire.
The majority of respondents were male because it is difficult
to get responses from females in the unmixed society which
exists in Saudi Arabia, especially in the middle region.

15

Figure 1
Questionnaire
These questions relate to our society in Saudi Arabia.

Please

answer them honestly and relate them'to our society.
Name:
Age:

---------------------------------------------------------------------------- Sex: --------------- Occupation:----------------

School:
City in Saudi Arabia that you came from:

1.

When do you go to the physician (doctor), or to the hospital?
a)
b)
c)

2.

always

c) sometimes

b) frequently

d) never

sometimes

b) frequently

c) always

d)

never

always

c) frequently

b) sometime.s

d) never

Do you visit more than one physician (doctor) for the same illness?
a)

7.

No

Do you use the medications of others (such as friends and relatives)
if you think your sickness is similar?
a)

6.

b)

Do you go to the pharmacy (drug stores) directly to get your
medication (treatment) without going to the physician?
a)

5.

Yes

After you feel better, do you continue to take your treatment (drugs)?
a)

4.

immediately after you feel sick
wait a while, and then go
only if you feel very sick

Do you always complete the course of medication (drug) which the
doctor prescribed for you (gave you) according to the directions?
a)

3.

----------------------~--------

sometimes

b) always

c) never

If you have drugs (medications) from past illnesses (diseases)
which the doctor gave you, do you use those medications (drugs)
without going to the doctor?
a)

Yes

b)

No

16
Figure 1.
8.

How would you like the pharmacist to give you information about
your treatment (medication, drugs)?
a)

9.

Continued

written

b) orally (verbally)

c) both

Do you think the time which the pharmacist spends with you at
windows of the pharmacy is enough to understand or to ask about
your medications?
a)

enough

b)

not enough

10.

What kind of information would you like the pharmacist to give
you concerning your treatment (your medications)?

11.

Are you satisfied with the services which the pharmacist gives
you in Saudi Arabia?
a)

Yes

b) No

If you answered NO, please explain: _______________________________

CHAPTER III
RESULTS
The questionnaire was completed by one hundred elever·
Saudi students living in the United States and 51 persons
living in Saudi Arabia.
~-

~--

The age and sex distribution of
~-----

-----

~~~-

-~~

~~~~---

---

-

----

---

~-~~-

--~--~-~~--

------~--~

the respondents living in the United States are given in ·
Table 3, and the age and sex distribution of 51 respondents
living in Saudi Arabia are given in Table 4.
The answers of each group are summarized in Table 5
(United States respondents) and Table 6 (Saudia Arabia
residents).

The answers to question #10 in Figure 1 and

part of answers to question 11 in Figure 1 were comments
from the respondents.
A comparison (Table 7) was made between the answers
of the que$tionnaire which was administered in Saudi
Arabia and the one which was sent to the students from
Saudi Arabia in the United States.

This comparison includes

the percentage of people from 51 Saudi Arabians who answered
the questions.

All of

these people were asked the same

questions (Figure 1) except question No. 7 which was inadvertently omitted to Saudi respondents living in Saudi
Arabia.
The answers to question #10, Figure 1, "What kind of
information would you like the pharmacist to give you
17

~--
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Table 3.

Gender
Males

The Age Distribution of Saudi Students in the
United States Responding to the Questionnaire.*
Age Range

Number
43

18-24

-

n

25-31

44

32-38

5
1

Over 38
------

93

Total

Female

Total

18-24

15

25-31

1

32-38

1

Over 38

1

18

*The majority of persons answering were males because the
majority of Saudi students in the United States are male.

19

Table 4.

Gender

The Age Distribution of the People in Saudi Arabia
Responding to the Questionnaire.*

Age Range

Number
-

R

Male

18-24

16

25-31

7

32-38

9
--------

Over 38
Total
Female

Total

-~~

12
44

18-24

3

25-31

1

32-38

1

Over 38

2
7

*The majority of persons answering were males because it
is difficult to get responses from females in the unmixed
society which exists in Saudi Arabia.

Table 5.

The Results of the Questionnaire From 111 Saudi Students in
the United States.

Questions

1.

2.

3.

4.

5.

Males

Females

Total (%)

When do you go to the doctor
or the hospital?

"'-

a.

immediately after feeling sick

26

4

b.

wait a while, and then go

27

5

30 (27%)
32 (29%)

c.

only if they feel very sick

40

9

49 (44%)

Do you always complete medicine
as prescribed by the doctor?
a.

Yes

51

10

61 (55%)

b.

No

42

8

50 (45%)

7

0

7 (6%)

After you feel better do you continue to take medicine as
prescribed?
a.

Always

b.

Frequently

17

5

22 (20%)

c.

Sometimes

7

48 (43%)

d.

Never

41
28

6

34 (31%)

53

8

60 (54%)

Do you go to the pharmacy directly to get medicine without going
to the doctor?
a.

Always

b.

Frequently

7

2

9 (8%)

c.

Sometimes

6

0

6 (6%)

d.

Never

28

8

36 (32%)

3

0

3 (3%)

Do you
others
if you
is the

use the medications of
(i.e. friends, relatives)
think that your sickness
same as theirs?

a.

Always

b.

Frequently

25

6

31 (28%)

c.

Sometimes

2

1

3 (3%)

d.

Never

63

11

74 (66%)

21

Table 5.

Continued

Questions

6.

7.

8.

9.

Females

Total (%)

53

12

65 (59%)

6

0

6 (5%)

34

6

40 (36%)

Males

Do you visit more than one physician
for the same illness?
a.

Sometimes

b.

Always

c.

Never

If you have a medicine for a
past illness (prescribed by a
doctor) would you use it again
for the same illness without
seeing the doctor?
a.

Yes

33

5

38

(34%)

b.

No

60

13

73

(66%)

27

1

28 (25%)

5

4

9 (8%)

61

13

74 (67%)

How would you like the pharmacist
to give you information about your
medicine?
a.

Written

b.

Verbally

c.

Both

Do you think the time the pharmacist
spends with you at the window is enough to ask or understand about your
medicine?
a.

Enough

27

5

32 (29%)

b.

Not Enough

66

13

79 (71%)

l l . Are you satisfied with pharmacists
services in Saudi Arabia?

a.

Yes

29

6

35 (32%)

b.

No

64

14

76 (68%)
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Table 6.

The Results of the Questionnaire Administered in Saudi
Arabia out of 51 Surveyed.

Questions
1.

2.

3.

4.

5.

Males

Females

Total (%)

When do you go to the doctor or
to the hospital?
9

1

10

(20%)

wait awhile, and then go

19

2

21

(41%)

only if they feel very sick

16

4

20

(39%)

37

2

39

(76%)

7

5

12

(24%)

(37%)
(63%)

a.

immediately after feeling sick

b.
c.

Do you always complete the course
of medication which the doctor
prescribed for you according to
the directions?
a.

Yes

b.

No

After you feel better do you continue to take your medication as
prescribed?
a.

Yes

18

1

b.

No

28

6

19
34

Do you go to the pharmacy directly
to get medicine without going to
the doctor?
a.

Yes

13

1

14

(28%)

b.

No

31

6

37

(72%)

Do you
others
if you
is the

use the medications of
(i.e., friends, relatives)
think that your sickness
same as theirs?

a.

Yes

12

4

16

(31%)

b.

No

32

3

35

(69%)

23
Table 6. .Continued
Questions

6.

Males

Females

Total (%)

Do you visit more than one physician
for the same illness?
a.

Yes

12

2

14

(28%)

b.

No

32

5

37

(72%)

20

5

25

(49%)

6

1

7

(14%)

18

1

19

(37%)

8. How would you like the pharmacist
------- --- to-give-you-information-about your
medication?

9.

11.

a.

written

b.

verbally

c.

both

Do you think the time which the
pharmacist spends with you at
the windows of the pharmacy is
enough to understand or to ask
about your medications?
a.

Enough

13

1

14

(2"8%)

b.

Not Enough

31

6

37

(72%)

Are you satisfied with the pharmacists
services which the pharmacist gives
you in Saudi Arabia?
a.

Yes

14

3

17

(34%)

b.

No

30

4

34

(66%)

Question No. 7 was inadvertently omitted.
Question No. 10 elicited comments from the respondents.

Table ].

Comparison of the Answers to the Questionnaires Administered
in the U.S.A. (111 persons) and Saudi Arabia (51 persons).

Questions
1.

-----------

Percentage of 111
students in the
United States (No.)

'l

When do you go to the doctor
or to the hospital?

-_a_.___irnrnedia~ely_after _you_
feel sick

2.

Percentage of 51
respondents in
Saudi Arabia (No.)

----------

20% (10)

27% (30)

b.

wait awhile, and then go

4i% (21)

29% (32)

c.

only if you feel very
sick

39% (20)

44% (49)

-----

Do you always complete your
medications as prescribed?
a.

Yes

76% (39)

55% (61)

b.

No

24% (12)

45% (SO)
·'

3.

4.

After you feel better do
you continue to take your
medication or treatment
as prescribed?
a.

sometimes

--*

43% (48)

b.

frequently

--*

20% (22)

c.

alway's (yes)

37% (19)

6% (7)

d.

never (no)

63% (32)

31% (34)

Do you go to the pharmacy
directly to get your medication (drug) without
going to the doctor or without a prescription?
a.

sometimes

--*

54% (60)

b.

frequently

--*

8% (9)

c.

always (yes)

28% (14)

5% (6)

d.

never (no)

72% (37)

32% (36)

-
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Table 7.

Continued

Questions
5.

----- - -

-------

6.

8.

9.

11.

Percentage of
respondents in
Saudi Arabia (No.)

Percentage of 111
students in the
United States (No.)

Do you use the medications of
others such as friends or relatives, if you think that your
sickness is the same?
a.

sometimes

_'J.,.-

.,:; _ _ ,.,. ........ -_.... _,_ ......

*
*

u-.-J.-.L-~quc11'-.L:/

c.

always (yes)

d.

never (no)

31%
69%

(16)
(35)

28%

(31)

---3%

(3)

3%
61%

(3)

(65)
(6)

-----

(74)

Do you visit more than one
physician for the same illness?

--*

a.

sometimes

b.

always (yes)

28%

(14)

c.

never (no)

72%

(37)

59%
5%
36%

(40)

How would you like the pharmaci~t to give you information
about your medication?
a.

written

49%

(25)

25%

(28)

b.

verbally

14%

(7)

9%

(9)

c.

both

37%

(19)

6.7%

(74)

(14)
(37)

29%

(32)

71%

(79)

Do you think the time which the
pharmacist spends with you at the
window of the pharmacy is enough
to understand or to ask about
your medications?
a.

Yes

28%

b.

No

72%

Are you satisfied with the services
which the pharmacist gives you in
Saudi Arabia?
a.

Yes

34%

(17)

32%. (35)

b.

No

66%

(34)

68%

(78)

*These choices were inadvertently omitted from the questionnaires administered in Saudi Arabia.
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concerning your treatment?"

can be summarized as follows:

1.

How to use the medication correctly.

2.

What the patient should do if there are any
adverse reactions.
~

Fl--

3.

What the patient should do if he forgets to.take
the medications.

4.

The possible side effects of the medications.

----------- --5---.-------Hew---lEJng--t-he---d-rug--shou-ld -be llSed--; -a-i1d -ir1f-ol~rnat-ion-- ------- ---

regarding necessity for refill.
6.

The storage of the medications, and the expiration
date.

·7.

If there are any foods which interfere with the
treatment.

8.

What the dangers of overdose are and what to do
if overdose occurs.

9.

Why the doctor gave them a specific drug for
their illness.

10.

Some information about their illness.

11.

Explanations of all information concerning their
treatment.

Question #11, Figure 1, asked, "Are you satisfied with
the services which the pharmacists give you in Saudi Arabia?"
Possible answers were "yes" or "no," and if the answer was
"no," an explanation was requested regarding dissatisfaction
with the service.
following:

The explanations are represented by the

-
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1.

Pharmacists do not care about the patients.

2.

Pharmacists are foreigners and they can not
speak Arabic.

3.

Pharmacists do not give enough information
to the patient.

4.

Pharmacists do not always give written instructions concerning the use of the medications.

5.

Limitation of time available with the pharmacist due to the crowds of people at the windows
of the pharmacies.

6.

Writing on the label is handwritten and is difficult or impossible to read.

7.

The explanations which are given orally do not
satisfy the patients because they are unable to
hear due to the noise from the crowds of waiting
people.

CHAPTER IV
DISCUSSION
Table 7 shows a comparison between responses from
Saudi students living in the United States and responses
from students residing in Saudi Arabia.

In response to ques-

tion No. 1, "When do you go to the physician (doctor) or the
hospital?" the two groups showed a similarity in that a
large .Percentage

of both groups chose the answer "only

if you feel very sick."

This indicates they may not realize

the dangerous nature of their illness.

Question 2 (Table 7)

asked, "Do you always complete the course of the medication
which the doctor prescribed for you according to the directqons?"

The answers given by the two groups show

that a

large percentage from both groups may not follow the instructions which were given and it indicates that this percentage
is greater among the students living in the United States than
among the correspondent living in.Saudi Arabia.

This indi-

cates that the role of the pharmacist is to inform the patient
whether he needs to refill the prescription or not, and to
emphasize that the patient must complete or continue to take
the medications as prescribed.
The patient often stops taking the medications at the
first sign of relief.

This is confirmed by the answers
28

29

to question No. 3 (Table 7) which asked, "After you feel
better do you continue to take your medication or treatment
as prescribed?" which indicated that a high percentage of
both groups never continued to take the medications after
they felt better.

The apparent discrepancy between the

responses to these two questions may be explained as follows:

Two responses were inadvertently omitted to Saudi

respondents living in Saudi Arabia.

It is possible that

persons who answered "Never" would have selected one of
the omitted

choices.

An alternative explanation is that

interpretation of the two questions is different.

The re-

spondents may have believed that they should have taken the
medications just until they felt better.

The responses

to question No. 5 (Table 7) which asked, "Do you use the
~edications of others such as friends or relatives if you

think that your sickness is the same?" indicated that one
third of each group may use the medications of friends or
relatives if they think their sickness is the same.

The

reasons why they would do this are unclear since health care
is provided without cost.

However, this is a frequent oc-

currence which may lead to dangerous complications of illness,
drug-drug interactions, or adverse drug reactions.

The pharma-

cists can improve patient medication compliance by the use
of the following procedures (11):
1.

Multiple medication consultation

2.

Patient follow-up reminders to reinforce patient's
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knowledge of proper self-administration techniques.
3.

Advising physician regarding patient medication
non-compliance.

4.

Medication consultation delivered in the proper
environment.

5.

Additional information in printed or handwritten
handouts presented to patient.

The factors which may lead to drug therapy problems
in outpatient clinics due to the services which are provided
to the patient include:
1.

Availability of non-narcotics and tranquilizers
without a prescription (5) which can lead to misuse
or abuse of the drugs, or to drug-drug interactions.
Question No. 4 (Table 7) asked "Do you go to the
pharmacy directly to get medicine (drugs) without
going to the doctor (without a prescription)?"
answers

ind~cated

The

that in both groups,there are some

who go directly to the pharmacy to get medications
without a prescription.
2.

Absence of a patient's medical record in the hospital
or in the pharmacy.

Even if the record exists, the

patient may go to another clinic or hospital and
because of this, it is difficult to recognize the
duplication of prescriptions.

In answers to ques-

tions No. 6 (Table 7) which asked, "Do you visit
more than one physician for the same illness?", the
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responses from the students from Saudi Arabia living
in the United States indicated that 65 of the 111
may see another doctor and may receive another
prescription.

They may use the two prescriptions

together or they may not.

Case III (6) in the

Introduction described a 60 year old man who had
visited two private doctors; each doctor gave him
a different hypoglycemic agent and he used both.
The answers to question Nd. 6 indicated that a significant part of the population change their doctor
quickly concerning the same illness because they
want an immediate cure from the first visit to the
doctor, and do not understand either their disease
or the treatment.
3.

Poor communication between the physician, pharmacists,
and the patient due to the language barrier and due
to the limited time which the physician and pharmacist spend with the patient.

Patient compliance can be improved by educating the
patient, and the most important factor is better communication between the patient and health care professionals.
Bal (12) has written about the communication problem of nonEnglish speaking persons in England.

He made several sug-

gestions for physicians to remember when they deal with nonEnglish speaking patients:

talk slowly, simply and clearly;

repeat words; avoid medical terms; and use logical sequence,
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illustrations, pictures, and models.
the use of an interpreter if possible.

He also recommended
On the other hand,

in Saudi Arabia the majority of the people speak the Arabic
'

language only and it is difficult for them to communicate
with the physician or pharmacists, or pharmacists assistants
who cannot speak Arabic.

Eliminating the language barrier

~-~ _may_p_]._a.y____a___S_:i_gnj__f_i_c~nt_r_o_l~

__in increasing_J2atient_co_mplian_ce--'-- -~-~--

Thus, the clinical pharmacist can play an active role in
determining outpatient problems associated with their therapy.
A study was done by Christensen, et al. (13) to determine
the nature and the extent of outpatient drug therapy problems encountered by the pharmacists.

It also described the

types of drugs which were most frequently involved in these
problems and the nature of changes in drug therapy problems
due to pharmacist's intervention.
marized as follows:

These problems can be sum-

(1) drug overuse, which included a

wide number of drugs but no specific predominant one;

(2)

drug overuse, with antihypertensives, diuretics, and potassium
supplements being the most frequently mentioned; (3) drug
interaction which was classified into two categories, life
threatening interaction such as phenylbutazone-warfarin, and
moderate or non-life threatening interactions such as antacids and tetracyclines.

The author concluded that there

were two to four potential drug therapy problems per hundred
prescriptions dispensed.

They demonstrated the importance

~~-
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of pharmacists in decreasing the incidence of these problems.
The amount of time the patient spends with the physician
or the pharmacist is very limited because of the crowds of
people waiting to be served.

In reply to question No. 9

-

n--

(Table 7) a high percentage of both groups indicated that
the pharmacist does not spend enough time at the window explaining uses of the medications.

This factor is caused by

the large number of people waiting for their medications and the
very little time the pharmacist assistant or the pharmacist
has to spend with each patient.

The large number of pres-

criptions that are filled may lead to mistakes in the filling
and little time with the patient to give instructions.

The

answers to question No. 8 (Table 7) which asked "How would
you like the pharmacist to give you information about your
medication?" indicate that a high percentage of the U.S.
respondents

would prefer both written and verbal instruc-

tions while the respondents living in Saudi Arabia would prefer written instructions.

In reply to question No. 10 (Figure

1) which asked, "What kind of information would you like the
pharmacist to give you concerning your treatment?", the
answers included the desire to know general information about
the medications such as usage, side effects, adverse reactions,
foods to avoid, storage, expiration date and specific information about the medications dispensed.

These responses were

similar to that which Herxheimer (14) suggested that the
patient may ask.
In the reply to question No. 9 (Table 7) which asked
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"Are you satisfied with the services which the pharmacist
gives you in Saudi Arabia?"

possible answers were "yes"

or "no," and if "no," an explanation was requested.

Ap-

proximately two thirds of each group were not satisfied
with the services which are provided and the explanations
were carelessness of the pharmacists, and poor communication with the pharmacist due to a) the language difference,
_____________b_)_l_imi_t_a±_i_o_n__ o_f_time--spent----Wi th----each-- pa-tient-,-- -c)-

c-~0\vds------------------

of people waiting and the high level of noise and inability
to hear what the pharmacist is saying.

The written instruc-

tions on the label are handwritten, difficult to read, and
lack adequate information given by the pharmacist.

CHAPTER V
-

"

CONCLUSION
The factors or reasons which usually lead to the in________cl'_ea~~~-~

!~c-~~-n~e

<:)_f_

::1.~""-'erse

drl1g reacti_on_s,

c!ru~-drug_

interactions, and. toxic reactions of medications in Saudi
Arabia have been discussed.

The out-patient in Saudi Arabia

does not. have a medical record in the outpatient department
or in the pharmacy.

It is important that hospitals and

pharmacies keep records for the patient in an organized
manner to avoid the duplication of prescriptions.

The

patient must be encouraged to cooperate with this system.
Since non-narcotic and tranquilizer drugs may be obtained without a prescription, it is important to follow the
law or the regulations i.f there are any, and restrict availability of these medicines from any hospital pharmacy or from
the market pharmacies without prescriptions.
There is poor communication between the physician· and
the patient and between the pharmacist and the patient due
to the language barrier and the limited time which the physician
and the pharmacist spend with the patient.

The physicians

and pharmacists who can speak the Arabic language should work
in outpatient departments, and those who cannot speak Arabic
should work inside the hospitals.
35

Currently the patient is assigned
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the name of a physician and then waits at the physician's
office door with many other patients until called; this
causes the physician to be in a hurry and spend less time
with each patient.
is recommended.

An appointment based on a triage system

Well experienced physicians working in the

admission office could screen and classify the patients depending on the type and severity of illness.

An appointment

should be given to those patients who can wait.

Patients

needing immediate care would be seen by the appropriate
physician.

This will reduce the pressure on the pharmacy

and will give the patient and the .pharmacist or pharmacist
assistant time to provide appropriate information and will
give the patient time ,to ask questions about his illness and
medications.
There is a lack of compliance by the patient regarding
instruction for his treatment.

Better patient compliance

can be obtained by use of appropriate publicity in television,
radio, newspapers, journals and by the introduction of health
education as a requirement in the secondary schools.
The pharmacist should play an active role in helping
solve these problems by monitoring drug therapy and thus
preventing adverse drug reactions and interactions.

Pharmacists

can advise patients about possible dietary (food-drug) interactions, or other medical problems which may interfere with
their treatment.

The pharmacist should verbally explain to

the patient the directions, possible side effects, and the
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proper storage of medications.

The pharmacist should provide

typed instructions on how .to use the drug, the expiration
date, the name of the doctor, and the name of the person for
whom the prescription is being filled.

This should be typed

on the label instead of handwritten and abbreviated.
Finally, the pharmacist must consider himself an educator and consultant regarding medications and health related
problems.

He should expand his role in these areas.

The

pharmacist must continue to study, and read journals to
maintain and improve his information skills.

The pharmacist

should attend continuing education programs or conferences,
have regular conferences with his colleagues, which will help
him to be up to date.
The pharmacist has a unique position to reinforce medication instructions and make a valuable contribution to the
durg therapy of each patient, since he is the last person
which the patient sees.

It is important for the patient to

be given instructions and information by the pharmacist regarding the illness and/or treatment.

This information should

be given verbally to those people who cannot read, and in
printed form explained in simple language for those who can
read.

He can provide printed pamphlets on specific diseases

or drugs.

He could prepare health educational materials for

.newspapers, television, radio to educate the public about
medications and their appropriate use.
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A proposal regarding the nature and level of information
which pharmacists should provide to Saudi patients on their
prescribed medications is presented in the appendix.

This

appendix does not represent all of the diseases which are
common in Saudi Arabia, but contains examples of some
classes of diseases which are mentioned in the introduction.
The information given for each disease can be used as a source
for additional labeling to provide more specific administration details, and to encourage the patient to participate in
his treatment.

It can also be used as a source of informa-

tion for patient education or for handouts which can be
given to the patient.
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INTRODUCTION
In a general public hospital or outpatient department,
the factors usually leading to the treatment-failure, increased incidence of adverse drug reactions and harmful
- - - -d-:rug-in-terae-t-:i:0ns-,-and--toxici ty of medi-cation are the follow-----

ing:

First, the patient rarely has a record in the hospital

or pharmacy; even if a medical record exists in a particular
hospital, the patient may go to another facility, making
the recognition of overlap or the duplication of prescriptions extremely difficult.

Second, the availability of non-

narcotics and tranquilizers without a prescription contributes to the misuse or abuse of a drug, or to adverse drug
reactions.

Third, the communication between physician or

pharmacist and the patient is usually very poor due to the
difference in language and background and the insufficient
amount of time devoted to each patient.
A questionnaire was developed and sent to Saudi students
in the United States and a sample in Saudi Arabia asking
them what they would like to know, in general, about diseases
and their treatment.

Their responses influenced the type

of information given for each of the selected diseases in
this appendix.

The ensuing body of information is neither

meant to be a comprehensive catalog of all diseases found in
Saudi Arabia, nor a replacement for the physician, but rather
42
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a proposal and aid to increase the awareness of the people
and to help the pharmacist or pharmacist assistant understand what the patient needs to know.

The aim of this paper

is to look briefly at each of· eleven diseases and conditions, focusing on the identification and methods of control of these diseases, instructions for the patient, the
role of the pharmacist both to help in public health educa-------------t-ie-n----o-f--t-hese and- ot-her- medical problems, as ---wel-1-- -as --to -hel-p-----------

decrease the incidence and improve the treatment of the
selected diseases.
The first two chapters deal with two parasitic diseases
common in Saudi Arabi, Giardiasis is common in Saudi Arabia
because of several factors:

First, the climate of Saudi

Arabia is hot and very suitable for parasites.

Second, there

are some customs, especially hand-shaking, because of infrequent hand washing, which aid in the transmission of this
disease.

Third, most of

th~

population eats by hand and often

people, especially children, do not wash their hands before
eating, leading to the increase in the incidence of Giardiasis
especially with children.
underdeveloped country.

Finally, Saudi Arabia is an
The majority of the population is

ot educated and poor sanitation exists almost everywhere.
-The second chapter deals with amebiasis.

Amebic dysen-

tery is probably the most important tropical infection present
in the Middle East, found in a large percentage of the population.

There are several factors which contribute to this

high percentage.

First, the climate is hot and suitable
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for parasites.
area.

Second, this infection is endemic in this

Finally, the large population of flies contributes

to the transmission of this infection.

Generally, the most

important promoting factor is the inadequacy of health
education to enable the people to prevent this disease.
The third chapter discusses trachoma, a major problem
in Saudi Arabia.
- - - - - - - - -- - - - -

It is worldwide

- - - - - - - - ----------

in distribution but it

------

is endemic in the Middle East.

The high prevalence is due

to the poor hygiene of people, the crowded living conditions,
and the dusty windy weather.
Sexually transmitted diseases are the topic of chapter
four.

They are worldwide, as well, and not usually reported

in Saudi Arabia because the patient does not often go to a
physician.
problem.

The refusal to report these diseases is a major
The reason that sexually transmitted diseases are

included in this section is to help young people and others
take care of these infections themselves and to help increase
their awareness of their hidden problems.
The fifth chapter focuses on peptic ulcer, the incidence of which is increasing rapidly due to changes in the
way of life and the daily living habits of the people.
There is increasing evidence of smoking and an increase in
stress.

There are many commonly used drugs which may induce

ulcers such as aspirin and phenylbutazone.
Chapter six is concerned with iron deficiency anemia,
common, particularly in children, due to malnutrition or
an unbalanced diet.

The incidence is also common in women
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because of frequent pregnancies and iron deficient diets.
The

sev~nth

chapter deals with rheumatoid arthritis.

This disease was selected because of the difficulties of its
management, the increase in the incidence of drug-drug
interactions and the frequency of self-treatment.
Chapter eight, concerning adult onset diabetes mellitus,
discusses this disease, and the symptoms and methods of
- -

-- --

moni tor1ng

------

fl:ie- c6ri.dT f ron-~-- ---

Hypertension in chapter nine is another important
factor, along with diabetes, in causing heart problems and
cerebral vascular accidnet, in Saudi Arabia.
Chapter ten discusses epilepsy, about which there are
some misconceptions heightening the chances for several
problems, such as uncontrolled seizures due to failure of
the treatment, drug interactions which interfere with the
treatment or adverse reactions from the treatment.
The Appendix concludes with glaucoma, which is common
in elderly people.

It is considered the first cause of

blindness and hence frustration for many people.
The role of the pharmacist for outclinic patients
includes consultation concerning the nature

~nd

symptoms of

the disease, and the nature of the medications used in'the
treatment of the disease.

In an attempt to achieve a

balance of information for each disease, each chapter
includes the following information:
1.

A description of the disease and possible cause;

2.

Drug treatment, usual drugs and dosage;

46

3.

Instructions to the pharmacist for each disease
and on his role in their treatment; and

4.

Instructions to be given to the patient
regarding the medication, and for infectious
---~

diseases, the means of preventing re-infection.

Chapter 1
I

GIARDIASIS INFECTION(S)
'

Giardiasis is an infection by the parasite called
Giaradia lamblia.
mitidea.

This parasite is from the family Hexa-

Motile giardia averages about 7 x 14 Mm and has

two nuclei and four pairs of flagella and has a specific
characteristic which is a suction disc on its ventral
surface.

The two stages of this parasite are (1) the tropho-

zoite which cannot live outside the body,

an~

(2) the

pathogenic cyst form which exist. as pairs (1).
are mainly man, pigs, and monkeys (2).

The hosts

The mode of trans-

mission is contaminated water, food and from one person to
another.

In Saudi Arabia flies play a major role in the

transmission of this disease.

The usual incubation period

is 15 days and the average duration of symptoms is 44 days
(1).

This parasite lives in the duodenum and upper part

of the jejunum.

The disease can be symptomatic.

The symp-

toms of long duration are diarrhea and accompanying weight
loss from dehydration, and abdominal pain.

The stool is

watery and odiferous and sometimes the stool·is accompanied
by mucous.

The disease interferes with intestinal functions

resulting in malabsorption of fat, vitamin A, glucose,
xylose, folic acid, and vitamin B12 (which can cause other
kinds of disease such as anemia) (13, 4, 5).
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This infection is most common in children, is the first
cause of steatorrhea and it mimes celiac disease (intestinal
malabsorption characterized by diarrhea, malnutrition,
bleeding tendency, and hypocalcemia) (4).

The diagnosis can

be confused with some kinds of allergies, such as milk
proteins.
Occurrence of this disease is worldwide, but it is more
common in areas with warm climate and poor sanitation.

The

susceptibility of the individual varies from one person to
another and depends on many factors such as age (the occurrence more common in the elderly and children than in young
adults).

Gastroectomy,. decreased gastric secretion, chronic

pancreatitis, and malnutrition enhance the susceptibility
of individuals (4).
The methods of control to prevent this infection are
numerous.

In general, the first thing is the health educa-

. tion of the people in order to increase the awareness about
this disease.

Second, the disposal of feces must be in a

suitable place, far away from the public water supply and
sewage systems should be improved.

Third, there should be

portection by chlorination of the public water supply from
contamination.

Fourth, victims and carriers (who work as

food handlers in restaurants and food markets especially),
must be educated regarding this infection.

However, there

is no isolation, quarantine or vaccination for this disease
(6), and finally, the containment of flies, both by insecticide and sanitary measures, should constitute a major effort.
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Treatment:

The treatment of giardiasis infection

depends on accurate diagnosis.

The diagnosis of this infec-

tion is very difficult and it is based on the microscopic
scanning for the cyst in the sample of feces, duodenum fluid,
and jejunum fluid.

Also, by the biopsy of intestine and

looking for trophozoite in the second stage (6).

Quinacrine

hydrochloride (Atabrine) is usually the drug of first choice.
The usual adult dose is 100 mg, three times daily for seven
days.

The dose for a child is 7 mgjkg of the body weight.

An alternative drug, metronidazole (Flagyl), is given 2 gm
daily for 3 days for an adult, 1 g daily for children above
7 years, 600 mg daily for children 3 to 7 years, and 400 mg
daily for an infant.

Some points should be discussed regard-

ing these two drugs for the treatment of giardiasis.

First,

quinacrine hydrochloride is a very toxic drug, the effects
of which include dizziness, headaches, mild gastrointestinal
disturbance, chronic dermatitis, yellow discoloration of the
skin after prolonged duration of use.

Second, the toxicity

of quinacrine is very dangerous and the treatment is as
follows:

If the patient needs respiration assistance, give

oxygen, and intravenous fluid, and a vasopressor for hypotension.
mended.

In acute toxicity, emesis or .aspiration is recomThe antidote is ammonium chloride which is admin-

istered at 12 gm daily by mouth for the purpose of enhancing
urinary excretion (8).

Finally, metronidazole (Flagyl) has

toxic effects, but less severe than quinacrine.

The side

effects are gastrointestinal disturbance, anorexia, nausea,
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vomiting, coated tongue, and darkening of the urine (8).
Metronidazole (Flagyl) is used with caution in pregnant
women because there are reports it may cause cancer and thus
is not recommended during the first trimester of pregnancy.
Also, metronidazole should not be given with alcohol because
it interferes with the metabolism of alcohol and produces a
disulfiram-like reaction.

Finally, metronidazole should not

be used in patients with blood dyscriasis.
Some Characteristics of These Drugs

Characteristics

Metronidazole

Quinacrine HCl

Description

white, creamy
crystalline

yellow, odorless

Taste

not bitter

bitter

Distribution

all over the
body

concentrates in
liver, pancreas,
spleen

Excretion

via urine

via urine

Half life

6.2 hours

5 days

Excreted in
breast milk

yes

yes

Storage

protect from
light

airtight; protect
from light

In conclusion, the best way to prevent this disease is
education of the people to control, prevent transmission,
and to help eradicate this disease.
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How to Prevent Infection from Giardiasis:
l.

Work toward the containment of flies inside the
house.

2.

Cover food and water to protect them from flies.

3.

Wash with water all fruits and vegetables before
eating them.

4.

Do not drink standing rain water.

5.

Use chlorinated water if possible, or boil the
water.

6.

Wash hands before and after eating.

7.

If one person in your family is infected, go
with him to the hospital and begin treatment.
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There is some information which the pharmacist should
tell the patient about the disease and the treatment:
Instructions to the Pharmacist

1.

Be sure to give the patient the right directions on how
to use the drug.

2.

Give the patient some information about the drug.

3.

Tell the patient "Do not drink alcohol."

4.

Tell the patient "There is some change in urine color.

5.

Tell the patient to complete the course and return to
the hospital again.

6.

Give the patient the directions on how to store the
medication including keeping the medication away from
children.

Instructions to the Patient

1.

Your m~dication (Flagyl) can undergo drug interaction
with alcohol, so there is some problem regarding the
intake of alcohol with this drug.

2.

Be sure to mention your medication to the other physicians or a lab manager who might want to take or to
measure thyroid function, as the Flagyl will interfere
with this.

3.

There will be changes in the color of your urine.

4.

Be sure there is no doubling of dosage and mention the
name of your medication to any other physician you visit.

5.

Return to the hospital after completing the course of
treatment; you may need another course of treatment.

6.

If you are a mother do not be confused between the
diarrhea resulting from the allergies from milk and this
disease.
Go to the hospital if a child has diarrhea.

Chapter 2
AMEBIASIS
Amebic dysentery is probably the most important tropical infection present in all of the Middle East.

This

infection is common in a large percentage of the population.
There are several factors which contribute to this high
percentage.

First, the climate

for this parasite to live.

o~

Saudi Arabia is suitable

Also, the large population of

flies contributes to transmitting this infection.

Second,

this infection is considered an epidemic in this area.

Saudi

Arabia now is one of the developing countries where medical
care is poor and the hygiene is sometimes very poor.
Finally, the most important factor is that the health education is insufficient to educate the people to prevent
this disease.

This chapter will brtefly discuss this

infection and its treatment, in hopes that it will help
people pay some attention to this infection, to help the
reader at least to consider this infection as a major problem, and perhaps eventually eliminate it.
The prevalence of amebiasis ranges from 5% in most
countries to 80% in countries with poor hygiene, especially
tropical and subtropical countries (9, 10).

The parasite

causing the infection is called Entamoeba histolytica.

This

parasite is mobile and has two stages cyst and trophozoite.
The trophozoite ranges from 10-60
53

vm,

and usually is 25

vm
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in length.

Also, the trophozoite has a nucleus which appears

as a halo or a ring under the microscope.

The cytoplasm

consists of granules, food vacuoles, and red blood cells
which the parasite has ingested.

The pathogenic stage is

the cysts which are able to survive outside a human body,
in contrast to the trophozoite which can only survive a
short period of time outside the human body (11).
acid resistant, the trophozoite is not contagious.
are acid resistant and can stay in the soil,
fomites a long period of time (10).

~ater

Not being
The cysts
or other

The mode of transmis-

sion for this disease depends on the mechanical transmission
of the cysts.

·rn Saudi Arabia, flies are considered the

major mode of transmission.

Food contamination by cysts

or water contamination, plays a role in the transmission of
pathogenic cysts (11).

Roaches can also carry the cysts

on their legs from feces to food or water and contribute to
spreading the disease.

Also, the cysts can spread from one

person to another by unclean hands.

This mode of spreading,

especially with food handlers and food stores, is a major
concern.
When a person ingests the cysts from one of the above
sources it causes infection, but if the person ingests the
trophozoite it is destroyed by gastric acid.

The major

problem is the asymptomatic infections in the carriers as
this person is the active source of the infection (10).

The

pathogenesis of infection begins when the person ingests
the cysts which are then converted to immature ameba going
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into the large intestine.

The immature ameba begins to

invade the mucosa by secretion of alytic substance, and
causes ulceration, from which the symptoms appear (10).
Entamoeba histolytica is not always pathogenic but sometimes can become pathogenic and cause serious disease under
specific conditions:

changing diet, increased cholesterol,

change in hormones, patient under heat stress, and
increased humidity.

All of these stimulate or contribute

toward changing the non-pathogens to pathogens.

The symp-

toms of the disease are different from one disease state to
another.

The acute form is different from the chronic.

Acute infection occurs after a large dose is ingested and is
characterized by diarrhea with blood and pus present, the
infection responded to treatment and is not serious if treated
effectively.

By contrast, the chronic illness is charac-

terized by mild diarrhea with episodes of constipation.
A complication of the infection is anemia, it resulting
from the loss of blood over a sustained period of time.
This anemia is iron deficiency anemia and can be corrected
by eating foods rich in iron, or an iron supplement (9).
Another dangerous complication is abscesses of the liver.
A recent study (14) showed some evidence that the abscesses
of the liver were due to Entamoeba histolytica infection.
Another possible complication is amebic pericarditis, which
is rare (14, 15).
The usual host is man.

Transmission occurs through

the shedding of cysts in the feces with subsequent
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contamination of food and water.

The usual incubation

period is two to four weeks, but the incubation period may
vary from only a few days to as long as several months.
There is no immunization against this parasite; but it is
not contagious and thus the patient need not be quarantined.
Amebiasis can be diagnosed ·in several ways.

First, the

diagnosis could depend on the microscopic examination of
different samples of feces, looking for cysts or trophozoites.
feces.

With acute infection, trophozoites are found in the
Also, stool specimens must be examined immediately

because trophozoites are destroyed by heat after a short
period of teim.

Second, an indirect hemaglutination test

on serum specimens could be administered (21).
could use an antibody test.

Third, one

This tests depends on the

indirect--immunoflorescence test (IFT) for the serologic
diagnosis of amebiasis.

It is uncomplicated to administer;

a few parasites need be present for diagnosis.

It is good

for identifying both acute and chronic infections (16).

The

fourth method of diagnosis is a liver scan for hepatic
amebic abscesses.
Another method of diagnosis is proctoscopy and obtaining a sample and identifying ulceration.

The parasite may

be isolated by being cultured in a suitable medium.

Any

one of the above methods is not enough alone to give an
accurate diagnosis of the illness, as there are different
species of amebic infection and other easily confused similar
infections, such as shigellosis, appendicitis, diverticulitts,
and giardiasis.
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The methods of control and prevention of the infection
depend on personal hygiene.

Some general principles to

limit the spread of the infection are listed below.
1.

The living environment inside the cities and villages must be made more sanitary.

2.

Human feces must be disposed of in a sanitary way
and covered.

3.

The government is responsible for the protection
of the public water supply, for using chlorine,
iodine or sand filter· to remove or destroy the
infectious cysts.

4.

Education is the best way to control the infection
by increasing the awareness of the people in regard
to hygiene and sanitatioti.

5.

Eradication or diminution of the disease would be
a major step to prevent transmission.

6.

The Department of Public Health must investigate
the restaurant workers and food handlers, and
enforce standards of cleanliness.

On the personal level there are many methods to prevent
the disease.
1.

Hand.washing after using the toilet, with hot
water and soap.

2.

Cover your food and your water to protect from the
flies.

3.

Use a suitable chemical to control the flies while
using covering or screening on the windows and doors.
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4.

Remove the garbage every day.

5.

Do not eat

v~getables

or fruit unless they are

washed with chlorinated water.

6.

Do not eat in restaurants where you are not sure
about standards of cleanliness.

7.

Wash your hands before eating any kind of food.

8.

Always use boiled or chlorinated water (17, 21).

Treatment:

The treatment of this infection varies with

case and place of infection.

Many drugs may be used.

The

following tables list these drugs, their characteristics
and uses.

·,,,

Drugs which are Used to Treat Amebiasis

Case
Asymptomatic

Drug of Choice
Diiodohydroxyquin
65 mg tid x 20 days
OR

Alternative
Metronidazole
75 mg tid x
10 days

Diloxanide Furoate
500 mg tid x 10 days
Mild infection

Paromycin 25 mgfkg
Metronidazole
in 3 doses for 10 days
+ Diiodohydroxyquin

Serious infection

Metronidazole+
Diiodohydroxyquin
or
Paromycin +
Diiodohydroxyquin

Emetine.HCl +
Paromycin

Hepatic Abscesses

Metronidazole
750 mg tid x 10 days

Emetine HCl +
chloroquine
phosphate

Drugs used in the treatment of Amebiasis

Side effects

Drug

Site of Action

Diiodohydroxyquin.:

Acts in the bowel
lumen

headache, pruritus,
enlarged thyroid,
optic neuritis

Diloxanide
Fur ate

bowel lumen

vomiting, pruritus,
urticatria,
flatulence

Drug interactions

Notes

Effect on blood
test because of
the presence of
iodine

high possibility of causing
neuritis

protect from
light
CJ1

Paromycin

bowel lumen

diarrhea, may
cause damage to
cranial nerve,
deafness, kidney
damage

I

I

I

malabsorption
syndrome with
sucrose

like neomycin,
avoid with
renal damage

.l:...

co

Drug
Metronidazole
(Flagyl)

Hechanism
Amebicidals

Side effects
gastrointestinal
disturbances,
anorexia, nausea,
vomiting, darkening
of the urine

Drug
Interaction

Comments

Alcohol

Avoid "tdth
alcohol

m

0

Emetine HCl

inhibits RNA
synthesis in
tissue of
organism
amebicide

degenerative
diseases of the
heart, kidney,
irritation causes
vomiting, nausea,
diarrhea, neuritic,
hypotension,
myocarditis

Chloroquine
Phosphate

inhibits protein
synthesis,

headache, pruritus,
gastrointestinal
disturbance, psychic,
drowsiness, convulsions, visual
disturbance

'I

I

antihypertensive
drug; there are
synergistic
effects

ECG monitor
is recommended

quick absorption, toxic
symptoms
within
30 minutes

r:; ......
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Instructions for the Pharmacists

(18, 19, 20)

1.

Most of the drug interactions, side effects, and adverse
reactions of these medications should be known.

2.

Store these medications in a place protected from light.

3.

Tell the patient about any change in urine color, such
as caused by Flagyl and chloroquine.

4.

Be familiar with the proper dose and the toxic dose and
how to treat toxicity.

5.

Remember all of these notes:
a.

Flagyl, as well as other drugs, is contraindicated
in pregnancy.

b.

Flagyl and chloroquine change urine color.

c.

Paromycin.interacts or interferes with absorption-the malabsorption syndrome.

d.

Diiodohydroxyquin interferes with blood tests.

e.

Emetine may cause hypotension and cardiac arrythmias.
It should be monitored in a hospital (ECG).

f.

Avoid emetine during pregnancy.

g.

Use emetine with caution in elderly.

h.

Emetine is contraindicated in cardiac problems, or
renal problems.

i.

Diiodohydroxyquin is contraindicated with an impaired
kidney or liver.

j.

Corticosteroids therapy should be avoided if the
patient has amebiasis because corticosteroids may
enhance the severity of the disease.

k.

Chloroquine phosphate should also be avoided during
pregnancy, hepatic disease, or in the case of
alcoholism.
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Instructions for the Patient (10, 19, 20)

A.

Be sure that you do not double the dose or take·another
drug which may interact with your medication.

B.

Tell your Doctor about any symptoms that you feel from
your medication.

C.

After you complete the course of the treatment return
to the hospital for a follow up examination.

D.

It is recommended that if you have an infection, go
with your entire family to be investigated.

E.

Do not take cortisone or an antiinflammatory drug as
you may aggravate your problem.

F.

Remember that the cleaner your are the safer will be
from infection recurring.

Chapter 3
TRACHOMA
Trachoma is a major problem in Saudi Arabia and other
Middle East countries.

It is a chronic disease caused by

Chlamidia trachomatis, and is considered the leading cause
of blindness in the world.

It is an infectious disease,

highly contagious, which infects the membrane lining of the
eyelids, covering the front of the eye.

The early or

initial symptoms o.f this disease include redness in one or
both eyes.

The eye becomes swollen and the patient may

feel a foreign body under the eyelids.

Additionally, the

patient is sensitive to light (photophobia) (22).
The incidence of this disease is high among children
of 8 to 10 years.

The.disease may progress to a conjuncti-

val scar and this may shrink causing the eyelid to turn
inward so that it blinks constantly.

It also may lead to

corneal ulceration which can cause blindness (23).

Acute

inflammation, combined with upper respiratory infections
such as sinusitis and otitis, is common.

The chronic

infection may produce kerato conjunctivitis which, involving
the cornea, turns to scar formation and reduces capacity
for sight (24, 25).
The causative agent is a Chlamydia, an obligate intracellular parasite.
virus and bacteria.

It has some characteristics of both
It is similar to a virus in its
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intracellular nature but differs by having DNA and RNA.

It

is similar to bacteria but lacks the mechanisms to produce
energy and therefore, depends on the host cells.

It can

survive in the host cells and multiply by binary fission.
These Chlamydia are incapable of synthesizing ATP and the
host cells supply them with it.

The genus is Chlamydia,

but this is further categorized as Chlamydia trachomatis,
Chlamydia psittaci.

The chlamydia trachomatis is involved

in trachoma and other diseases such as bilateral interstitial
pneumonia, nongonococcal urethritis, salpingitis, cervicitis, and conjunctivitis (22).
It occurs worldwide, but is endemic in the Middle East.
The high prevalence is due to first, the poor hygiene of
the society; second, the crowded living conditions; third,
the dusty windy weather also helps to increase the prevalence (22, 23, 24).

The reservoir and the source of this

infection is children under age 10, and usually under age
five (23).

The methods of transmission are numerous, but

the most important factors are:
1.

close contact eye to eye

2.

birth canal infection, especially in the newborn

3.

flies may carry Chlamydia from the discharge of
an infected eye.

4.

certain articles which come in contact with an
infected person.

Trachoma is considered the disease of the family,
especially in a crowded family with many children.

Reinfection
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is common especially in children in an area where trachoma
is endemic (23).

The infection is characterized by intra-

familial transmission in Saudi Arabia (28).
may be latent.

The infection

The infection does not express itself until

a period of time when a person visits an endemic area, and
anyone who has not had childhood trachoma may develop acute
trachoma later.
The diagnosis is based on:
1.

eye exam

2.

looking under the microscope for cytoplasmic
inclusion bodies

3.

Chlamydia isolation

4.

human serology (complement fixation) (22)

To prevent the infection on the individual person
level, there are some guides to follows:
1.

apply ointment (antibiotic) on each eye of newborn
baby.

2.

exclude the infected child from school.

3.

improve the standard of cleanliness to avoid
infection.

4.

do not use the articles whic~ belong to others
who are infected.

5.

use your own personal towels or articles which
belong to you.

6.

do not have contact with an infected patient.
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There are several methods to control this infection on
the societal level.
1.

the most important factor is the education of the
people to improve their personal hygiene.

2.

educate the people to use individual towels, and
toilet articles, and do not use other people's
articles.

3.

control flies by screening the doors and windows,
and using suitable chemical sprays.

4.

remove the garbage and eliminate the flies'
breeding place.

5.

begin investigation and screening of all preschool
children, and treat the infected child.

Treatment:

Tetracycline orally is the drug of choice

for treatment of Chlamydia infection.

It is bacteriostatic

which inhibits the protein synthesis of Chlamydia.
are three types of tetracycline:
and long acting.
forms:

There

short acting, intermediate,

They are available in different dosage

capsules, tablets, injections, and also ointment

1% - 3% as tetracycline hydrochloride.
typically:

The usual dose is

1% - 3% ointment, tablets of 250 mg or 500 mg

three times daily for an adult (26).
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Instructions to the Pharmacist

1.

Tetracycline will interfere with bone growth. Avoid
dispensing tetracycline to pregnant women or young
children.

2.

Tetracycline is used with caution especially in renal
failure patient.

3.

Avoid dispensing Tetracycline to children up to 12
years of age because it will cause permanent discoloration of child's teeth.

4.

It should not be given with any hepatotoxic agents.

5.

Tetracycline may cause a deficiency in folate and
cause anemia.

6.

Protect tetracycline from light to avoid photodegradation.

7.

Remove any tetracycline with darkening or change in color
from your counter.

8.

Tetracycline loses potency of approximately 10% when it
is stored at 370 for 2 months.

9.

Be sure you give the patient the adequate dose and be
sure that he is not taking cortisone or antacids with
it.

10.

Tetracycline has· many side' effects, including
Gastrointestinal disturbance, vitamin deficiency, increase incidence of infection by Giardiasis, teeth
discoloration (in children) photosensitivity, and increased fat in the liver.
(29).

11.

Erythromycin can be used as alternative to tetracycline.
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Instruction for Patient
1 . . You should not take tetracycline with milk or buttermilk because these contain magnesium and calcium which
decreases absorption of the tetracycline.
2.

Be sure you do not take tetracycline with alcohol because alcohol increase the metabolism of tetracycline.

3.

Be sure do not mix tetracycline with antacid because
this will decrease the absorption of tetracycline.

4.

Do not take tetracycline especially if you are pregnant or nursing a child.

5.

Avoid the sunlight especially for a long time because
of photosensitivty.

6.

Report any side effects or adverse reactions to your
physician or pharmacist.

Chapter 4
SEXUALLY TRANSMITTED DISEASES
There are many sexually transmitted diseases.

The

route of transmission is the same but the causative agents
are different.

The most common sexually transmitted diseases

are described, and emphasized will be gonorrhea, being the
most common in Saudi Arabia.

The incidence of these

diseases is different from one disease to another.

The

most common diseases shown in the following pages are
adapted from American Pharmacy, Vol. NS20, No. 8, August
1980, page 35.
The first disease is gonorrhea; the symptoms of
gonorrhea are different for the male than for the female.
In women it is usually asumptomatic; but if there are symptoms they are usually characterized by vaginal discharge
and cystitis.

In the male symptoms are dysuria, urethral

discharge, and pain during urination (30).
The diagnosis of gonorrhea depends on the microscopic
examination and culture of the microorganism.

The treatment

of gonorrhea is by antibiotics such as Penicillin G, 4.8
million units by intramuscular injection in two different
sites.

Probenecid is used orally to enhance or increase

the peak serum of penicillin.

The alternative is tetra-

cycline--0.5 gm orally, four times daily, for 5 to 10 days.
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Gonorrhea is an infectious disease caused by Neisseria
gonorrhoeae.

Neisseria gonorrhoeae is gram negative diplo-

cocci bacteria.
is the human.

The host of this gram negative bacteria
It causes a frequent purulent urethritis in

men and purulent vaginitis in women, purulent conjunctivitis
in the newborn child, and gonococcal proctitis in both women
and men.

Also Niesseria Gonorrhaeae causes salpingitis

(pelvic inflammation in women) and also purulent arthritis
(31).

If the infection is not treated it may cause septi-

cemia with pustulor skin lesions, fever, and chronic prostatitis, especially if it disseminates (32).
The symptoms of Gonorrhea in men are purulent urethral
discharge, dysuria, frequent urination, and it may be
asymptomatic.

This asymptomatic infection is the frequent

source of infection and it works as a carrier.

The symptoms

of gonorrhea in women are dysuria, frequent urination, an
increase in vaginal discharge, abnormal menstrual bleeding,
anorectal discomfort, cystitis, and also may be asymptomatic.
The occurrence of purulent urethral discharge for four
to ten days after sexual contact is sufficient evidence to
make presumptive diagnosis.

In women this is very difficult

because the asymptomatic is most common.
Diagnosis Gonorrhea in women depends on:
1.

A smear looking for intracellular gram negative

bacteria diplococci.
2.

Thayer-Montin Media, culture the exudate in enriched

chocolate agar with some antibiotics such as vancomycin,
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nystatin to eliminate the growth of other bacteria or fungi.
The specimen should be taken from the endocervical of the
woman.
3.

Coagulatination test.

4.

Serological test especially the tests which dis-

tinguish syphilis from gonorrhea.
Transmission of the Microorganism-The major route of transmission is by sexual contact
of an infectious person.

There is a myth that gonorrhea or

other sexually transmitted diseases are transmitted by
articles or by the hands (33).

The second route of trans-

mission is the infected birth canal.
infected especially in the eyes.

The newborn can be

This may result in

gonococcal ophthalmia neonatorum especially if the 1%
silver

ni~rate

drops or antibiotic eye ointments are not

administered (34).
How to Prevent the Infection
1.

Use a condom during sexual contact.

2.

Urination immediately following intercourse may be
helpful, especially in men.

3.

Washing the genitalia with water and soap.

4.

Use antibiotics cream or foam for prophylaxis.

5.

Some have recommended Penicillin G in a dose of one
million units immediately before and after.

6.

To prevent the gonococcal ophthalmia neonatorium, apply
to the eyes of newborn 1% silver nitrate solution or
an antibiotic ointment.
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The second disease is syphilis (31), of which there
are two types:

primary syphilis and secondary syphilis.

The primary syphilis is characterized by a painless chancre.
Secondary syphilis is characterized by cutaneous and mucous
membrane lesion, alopecia, and generalized lymphoadenopathy.
The diagnosis of syphilis is derived by a VDRL (Venereal
Disease Research Laboratory) test or RPR (Rabid Plasma
Reagin) or by use of an electron microscope.

The treatment

of syphilis is by benzathine penicillin G--2.4 million units
IM, or procaine penicillin G--4.8 million units (600,000
units IM daily for 8 days).
The third disease is nongonococcal urethritis (NGU).
It is characterized by urethral discharge, purulent or mucoid.
The diagnosis depends on the clinical picture of the symptoms.

It also depends on the microscope and culture to

distinguish NGU from the Neisseria gonorrhoeae.

The usual

treatment is tetracycline, 0.5 gm four times daily for
21 days.
The fourth disease is trichomoniasis, a protozoan
infection (T. vaginalis).

It is characterized by erythema

and edema of the external genitalia, a greenish-gray vaginal
discharge, or it may be asymptomatic.

The diagnosis depends

on the micDoscopical examination of the discharge and the
treatment is Flagyl, 2 gm orally, or 250 mg three times
daily for seven days.
The fifth disease is virus-caused genital herpes.
infection is characterized by vesicular lesions in the

This
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vulva, vagina, and the cervix in the women, or lesions
in penis prepuse and scrotum in men.

The diagnosis is made

by microscopical examination to eliminate other diseases.
There is no specific treatment.
The sixth disease is vulvovaginal candidiasis--a mycotic
infection.

It is a common infectious disease of the vulva.

It is characterized by erythematous and edematous vaginal
discharge which is characterized by a white, thick color.
The diagnosis depends on the culture or by the microscopical
examination.
to~ies

The treatment is nystatin vaginal supposi-

inserted twice daily for 14 days.

The seventh disease is Corynbacterium Vaginale Vaginitis.

This disease is characterized by gray white discharge

and vulvular irritation.

The diagnosis depends on the

clinical picture of the symptoms and also the microscopical
examination.

The treatment is by ampicillin--500 mg every

six hours for 10 days."
Anther problem is pediculosis pubis, known as "Crabs,"
which is characterized by erythematous, itching papules.
Nits, larvae or adult lice stick to the hair around the
pubic area or hair around the anus.
on clinical observation of lice.

The diagnosis depends

The treatment is usually

1% gama benzene hexachloride lotion or 25% benzyl benzoate
lotion combined with antibiotics to prevent secondary
infection.
The next disease is Scabies.

This infection is char-

acterized by the red papule which containes the mite.

The
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scratching may produce excoriation.

This is most common on

fingers, wrists, elbows, ankles, and waist.
terized by night-time itching.

It is

charac~

The treatment is as for

pediculosis.
Genital Warts is a disease characterized by pinkish
papillary growth which occurs around the vulva introitus.
The diagnosis depends on the clinical appearance and histological observation.

The treatment is podophyllin; 10-25%

in tincture of benzoin, applied weekly.
Chancroid is a tender ulcer (soft chancre).

The base

of this ulcer is covered by yellow or gray necrotic exudate.
The diagnosis depends on the clinical appearance and on the
test which distinguishes the Chancroid from syphilis.

The

treatment is by sulfisoxazole--1 gm orally four times.
Lymphogranuloma venereum, is characterized by painless
vesicles or superficial nonindurated ulcers on the genitalia.
This is diagnosea by the clinical picture or by the complement fixation test.

The treatment is by tetracycline--500 mg

orally four times a day for 2 to 3 weeks.
The disease granuloma inguinale is detected by subcutaneous nodules which erode through the skin producing
clean granulomatous beefy red lesions.
on the clinical picture.

The diagnosis depends

The treatment is tetracycline

0.2 gm four times a day for 3 weeks.
Hepatitis Type B is an insidious onset infection characterized by abdominal discomfort, anorexia, nausea, vomiting.
If this disease progresses it may lead to jaundice.

75

Instructions to the Pharmacist

1.

First of all, do not prescribe any medication to any
person who thinks they may have a sexually transmitted
disease unless he has first seen a doctor.

2.

Learn the current treatment schedule for uncomplicated
gonorrhea.

3.

Tetracycline should be avoided in pregnant women.

4.

Remember there may be drug interactions with tetracycline, such as with antacids or milk products.

5.

Probenicid is used with penicillin to increase the peak
serum level of penicillin.

6.

Probenicid may cause nausea, vomiting, precipitate uric
acid stone and primary gouty arthritis.

Instructions for the Patient

l.

If you have the symptoms of gonorrhea do not hesitate
to visit the doctor as soon as possible.

2.

The treatment is usually penicillin.
tive to penicillin tell your doctor.

3.

Avoid contact with your partner(s).

4.

Personal cleanliness is important.

5.

Avoid the causes which lead to reinfection.

6.

If you have gout tell your doctor because he may
prescribe probenicid.

7.

Pregnant women should avoid tetracycline.

8.

Follow the treatment accurately (30, 32).

If you are sensi-

Chapter 5
PEPTIC ULCER
Peptic ulcer is a term used to represent the ulcerative
disorder of the upper gastrointestinal tract.

Peptic ulcer

includes three different types of ulcers, gastric ulcer,
duodenum ulcer, and Zollinger-Ellison syndrome (35).

Each

of these three ulcers varies in incidence and specific character (37).
The incidence of peptic ulcer in the male is higher
than in the female because of the hormonal protection in the
female.

The duodenal ulcer is more common than the gastric

ulcer, and more common in younger people between 25-50 years;
in contrast, gastric ulcer is more common in older people.
The differences between gastric and duodenal ulcer are in
areas of location, severity, and cause (36).

First, the

location of the duodenal ulcer is in the first segment of
duodenum but the gastric ulcer is found on the wall of
the stomach, making treatment more difficult.

Secondly,

the duodenal ulcer is a benign ulcer, while the gastric ulcer
may be malignant.

Finally, the amount of hydrochloric acid

secretion differs from the gastric ulcer to the duodenal
ulcer.

The acid secretion associated with a duodenal ulcer

is more than the normal which would exist with no ulcer; and
in the gastric ulcer, the secretion is normal or may be
lower than normal.
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There are several causes of the duodenal ulcer.
causes may be endogenous or exogenous.

These

The endogenous

causes are increasing vagus nerves stimulation, increasing
gastric and secretion or gastric acid overproduction, increasing vulnerability of mucosa, gastric mucosal atrophy and
the inflammation of gastroduodenum mucosa (gastritis) (37).
The exogenous causes which may lead to ulceration are
stress (which includes emotional stress, stress due to operations), burns, or a type of stress prone personality known
as Type A personality.

Genetic factors may have an influ-

ence such as blood group 0.

Also, drugs which may induce

ulcers are most common, and numerous.

Some of the more

important drugs are aspirin, phenylbutazone, indomethacin,
reserpine, alcohol, caffeine, cigarettes, potassium chloride
tablets, and corticosteroids.

Reserpine and caffeine

increase acid secretion; and alcohol causes gastritis as
well as local irritation (37).
The symptoms of peptic ulcer (duodenal ulcer) are epigastric pain, characterized by "heart burn,'' an increased
sensation of hunger, and fullness in the right middle
epigastrium especially about 90 minutes after eating.

This

pain is relieved by food or by using an antacid or even
vomiting.

Also, there are symptoms of the gastrointestinal

tract which include nausea, vomiting, indigestion, constipation, and the vomit may contain blood (coffee ground
vomiting( (35, 37).
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There are several complications associated with peptic
ulcer.
A.

A chronic loss of blood causing anemia, i.e.,

hypochromic microcytic anemia.
B.

The ulcer may penetrate the stomach wall and include

other organs such as the pancreas.
C.

Perforation may occur in which the ulcer eats the

gastric or duodenum wall due to erosions to the pentionium
cavity.

Food which is contaminated enters the cavity caus-

ing peritonitis and septicemia.

Besides these, there may

be pyleoric obstruction with continuous vomiting.
The diagnosis of peptic ulcer is usually made with the
first signs and symptoms.

The pain which is relieved by

food or antacid is evidence or at least a suggestion of
duodenal ulcer.

Also, there are several x-ray examinations.

The barium examinations of the upper gastrointestinal tract,
endoscopy, intragastric photography, or the multiple purpose
endoscope (36) are used to diagnose this condition.
The treatment of peptic ulcer is basically life-long.
The goal of treatment is to prevent the recurrence of the
ulcer and to heal the present ulcer, by decreasing gastric
acidity and to relieve pain and stress.
First of all, diet is very important.

The diet must

be nutritious with a restricted intake of gastric irritants;
such as alcohol) coffee, tea, chilies, peppers, or other
hot foods.

It is recommended to take frequent small meals.

Using milk to neutralize the acid has some advantage, but
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there are disadvantages.

Milk has poor neutralizing power,

and is also rich in lipids which may increase chances of
heart diseases.

Also, milk protein increases acid secre-

tion and has a high amount of calcium which influences the
heart function.
The second step is the use of antacids.

Antacids

neutralize acid, but have no healing function or cure.
Antacid drugs are selected based upon the neutralization
capacity and sodium content.

The best antacid is an antacid

which has high neutralizing power, and an absence of acid
rebound, with no constipation or diarrhea as adverse reactions, or side effects.

Also, a good antacid has no influ-

ence on the electrolyte balance.
There are several antacid preparations and some of
these are:

sodium bicarbonate preparations, which are

potent and short term, rapidly acting, but may cause
systemic alkalosis if a more than 200 m Eq NaHC0 3 Sodium
Bicarbonate to a patient under the age of 60 years old, or
if given by 100 m Eq to a patient above 60 years old.

The

second preparation which frequently described is aluminum
hydroxide, and it causes constipation.

It may be pre-

scribed alone or with magnesium hydroxide to neutralize
the acid and the side effects of aluminum hydroxide.

The

third preparation is magnesium hydroxide and it is poorly
absorbed by the intestine and may cause osmotic diarrhea.
It is used usually in combination with aluminum hydroxide.
The fourth preparation contains calcium carbonate, and
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prolonged use may cause adverse reactions such as producing
calculi, acid rebound and hypercalcemia.

Anticholinergic

drugs such as atropine and probanthine but they are not
,recommended.

This group is not recommended because the

amount of drug to neutralize or to inhibit the vagus is
close to the toxic dose.

The side effects of these medica-

tions are dry mouth, blurred vision, confusion, and may
cause tacchycardia (37, 38, 40, 41).
The next group is H2 antagonists, or histamine antagonists. Emetidine (tagamet) is an example of this group and
the usual dose of cemitidine (tagamet) is 300 mg four times
daily.

It is used as a prophylactic as well.

The side

effects may induce mastitis, and maybe mental confusion,
especially in old people.
is surgery.

The last solution or treatment

Surgery is not done except if there is a high

recurrence rate or frequent complications such as penetration, perforation, or obstruction.

Surgery is also done

when there is a malignancy (40).
In conclusion, the selection of antacids
situation of the patient and the diagnosis.

dep~nds

on the

The patient may

have heart failure and need restricted sodium intake.
must be treated by low sodium antacids.

He

Also the treatment

complication which is associated with peptic ulcer is very
important.

It is very difficult to manage a patient with

peptic ulcer who also has rheumatoid arthritis or gout.

Remem-

ber that you should not prescribe any medication without having
proper information and background on the patient.
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Instructions for the Pharmacist

1.

Remeber that all of the drugs which are used to neutralize acids may have interactions with other drugs.
a)

Tetracycline should not be administered with an
antacid.

b)

With digitalis it is very important to monitor the
dose. Antacid impairs the absorption.

c)

Naproxen absorption is delayed by an antacid.

d)

An antanid increases the levodopa absorption.

e)

An antacid decreases iron absorption, especially
magnesium trisilicate.

f)

Indomethacin is inhibited by an antacid due to
decreased absorption.

g)

An antacid reduces the rate of librium absorption.

h)

Oral anticoagulents should not be used with an
antacid. If the patient needs to use ah anticoagulant, he should use only warfarin.

2.

Remember the list of ulcerogenic drugs such as aspirin,
indomethacin, phenylbutazone, cortisone, reserpine, and
potassium chloride tablets.

3.

Remember that the patient who has a peptic ulcer may
develop hypochromic microcytic anemia (iron deficiency
anemia).

4.

Remember that these drugs should be taken 1 hour after
a meal except if the physician orders otherwise.

5.

Remember the dose must be reduced if the patient has
renal insufficiency.

6.

Selection of the antacid is based upon the neutralizing
capacity and also upon the sodium content, especially
with a patient who has a peptic ulcer and other disorders, such as hypertension and congestive heart
failure.

7.

There are many products.
in the following table.

The most common are listed
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Product

Ingredient

Neutralizing
Capacity

Aludrox

Aluminum Hydroxide
+ Magnesium.Hydroxide

42

Amphojel

Aluminum Hydroxide

29

Camalox

Aluminum Hydroxide,
Calcium Carbonate,
+ Magnesium Hydroxide

54

Ducon

Aluminum Hydroxide,
Calcium Carbonate,
+ Magnesium Hydroxide

105

Gelusil

Aluminum Hydroxide,
Magnesium Hydroxide,
Simethica

36

Maalox

Aluminum Hydroxide,
Magnesium Hydroxide

39

Gelusil II

Aluminum Hydroxide,
Magnesium Hydroxide
Simethica

71

Milk of Magnesia

Magnesium Hydrate

35

Riopan

Magnesium Aidrate

33

Titralic

Calcium Carbonate

35

~

(Adapted from the Handbook of Clinical Drug Data, p. 377).
8.

You may find other preparations which are used to
treat Peptic Ulcer especially from Europe, such as
licorice derivatives, or antipepsins, or antigastrics.

9.

Some use hormones such as estrogen (36).
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Instructions for the Patient

1.

Avoid gastric irritant foods such as chilies, alcohol,
tea, green chilies, hot peppers, smoking, cola, coffee,
or any type of food or activity you feel is a gastric
irritant.

2.

Avoid the ulcerogenic drugs such as asp1r1n, indomethacin, phenylbutazone, reserpine, potassium chloride
tablets, and cortisone.

3.

Take rich nutritional food in small meals many times
a day.

4.

Use the antacid which your physician prescribed for you
and report anything about the drug to your physician.

5.

Rep0rt any side effects of tagamet to your physician.

6.

Avoid situations which lead to stress, accept the
disease and therapy and learn how to manage it.

7.

Remember that ulcers are never completely healed and
may recur. You must use the antacid as long as you live.

8.

Visit your physician regularly (37, 41).

Chapter 6
IRON DEFICIENCY ANEMIA
Iron deficiency anemia is the most common anemia in
Saudi Arabia, as it is world wide.

It occurs especially in

pregnant women and in preschool children, although found
in all ages.

Iron deficiency anemia is microcytic hypo-

chromic anemia, meaning the red blood cells are small and
pale.

The hemoglobin is very important for the transpor-

tation of oxygen and carbon monoxide from tissue to the
lungs.

When iron deficiency occurs, the production of the

blood cells is less effective and the formation of the
hemoglobin content is affected.

The red blood cells, being

small. and pale, reduce the capacity of the blood to maintain
normal oxygen transportation (43).
The symptoms of iron deficiency anemia are numerous
and depend on the degree of the severity of 'the deficiency.
Most cases are asymptomatic, but if a case is symptomatic,
it will be manifested by these symptoms:

fatigability,

faintness, palpitations, shortness of breath, headache and
pallor.

Pregnant women as well as children may feel a

strange appetite which is called pica; there is often an
abnormal appetite for clay, ice and other things that are
not fit for food.
There are several causes of anemia due to iron deficiency (44).

The first cause is an imbalance in diet.
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Iron
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is naturally absorbed and the excess is deposited in storage,
as the body's reserve, in the hepatic epithelium.

The

daily iron requirement differs from one individual to
another.

For example, the normal man and non-menstruating

woman need 5-10 mg daily.
7-20 mg daily.

The menstruating woman needs

The pregnant woman needs 20-40 mg daily.

Iron is found in the following kinds of foods:

liver, meat,

whole grains, potatoes, egg yolks, green vegetables, and
fruits (43).

It is very important that there be an adequate

diet with a good selection of the above for children,
especially preschool children.

The infant after six months

of age will deplete all of the iron storage which he had from
his mother.

Now he needs iron from external sources.

Chil-

dren often develop milk anemia due to lack of iron in their
Xood.

The second cause is the failure to absorb the iron

from the food which is ingested.

This cause may be secondary

to gastrointestinal diseases or malabsorption (45).
third cause is loss of blood.

The

This is the most common

cause of iron deficiency anemia.

The chronic loss of blood

causes the iron deficiency and develops the anemia.

This

cause can be resultant from several factors.
a. Ulceration in the gastrointestinal

tract~

such as

peptic ulcer of duodenal ulcer, leading to iron
deficiency.
b. Hookworm infection which will consume the food and
also cause internal bleeding.

The hookworm produces

~--
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chronic bleeding and the iron escapes with the
b1ood.
c.

Drugs, such as aspirin and phenylbutazone, may
also induce irritation and bleeding in the gastrointestinal tract.

The fourth case is frequent pregnancy.

Pregnancy

increases the demand for as well as the loss of iron because
of the large amount of blood lost during labor.

Infections

such as tuberculosis or autoimmune diseases such as rheumatoid arthritis will prevent iron utilization and cause iron
deficiency .anemia.

Finally, lack of hydrochloric acid, or

lack of Vitamin B6 may cause anemia (44).
The diagnosis of iron deficiency anemia depends on the
severity of this deficiency.

When iron storage has been

depleted, plasma iron falls and erythropoesis is curtailed.
Red blood cells may be morphologically normal (normocytic).
The results of iron deficiency may be one or more of
these:
a)

Plasma iron level is decreased.

b)

Iron binding capacity is increased.

c)

Transferrin saturation is about 5-15% and the
normal is usually 10-20%.

d)

Sideroblasts are decreased.

e)

The morphologic shape is normocytic or microcytic
hypochromic.

There are some laboratory tests such as a) microscopical
examination of smear of marrow aspirate for hemoiderin
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granules, b) the plasma levels iron values decreased, and
c) if the level is less than 50 mgjlOOml then the patient
is considered anemic.
How to Prevent Iron Deficiency Anemia

A)

A good diet containing meat, liver, eggs, and green
vegetables is very important to maintain adequate iron
level.

B)

Do not depend on one kind of diet such as rice, and do
not eat at irregular intervals, or miss breakfast.

C)

Pay attention to the children and their diet.
them foods containing iron.

D)

Pay attention to a child, to see if he has pica, and
the pregnant woman should pay attention to her own
appetite.

E)

Correct the causes of the iron deficiency before you
treat anemia.

F)

Vigorous exercise should be avoided if you have anemia.

G)

Pregnant women should visit the physician regularly
during pregnancy (43)~

Give

.The treatment of iron deficiency anemia is simple.
treat the cause by giving iron supplement (47).

Just

There are

oral preparations which are ferrous salts such as sulfate,
gluconate, and fumarate.
daily.

The usual oral dose is 200 mg

The oral iron supplement is preferable to the

parenterally supplement.
The parenteral supplement is iron dextran.

This injec-

tion is not recommended except when there are some factors
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which force you to use it.

These factors are:

oral malab-

sorption, serious gastrointestinal disturbance, ulceration
in the stomach or in any part of the gastrointestinal tract,
and gastrointestinal infection.
The iron supplement which is given orally is transported
across the intestinal mucosa and it is carried by transferrin
to the erythroid marrow.

The parenteral iron dextran is

metabolized by the liver parenchyma and reticuloendothelial
cells.

Then the iron containing carbohydrates split, and

the free iron is carried by transferrin to the bone marrow.
The dose of ferrous sulfate is 200 mg twice daily for
at least three months (44).

The side effects of iron

prepa~

rations may be gastrointestinal irritation, constipation,
diarrhea, stained teeth, and sometimes acute poisoning,
especially in children (49).
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Instructions for the Pharmacist

A.

All iron preparations should be labeled "Caution! Keep
out of reach of children." Acute poisoning is very common among children. A dose of 1 gm can cause acute
poisoning.
·
. The symptoms of poisoning:
Gastric irritation, necrosis, nausea, vomiting,
shock, pallor, cyanosis, drowsiness, and the
stool color is green.
Treatment:
1.
2.
3.
4.

Induction of vomiting
Administration of eggs and milk
Gastric lavage
1% sodium bicarbonate to-convert iron to a
less soluble compound.
5 . . Chelating agent may be used such as deferoxamine.

B.

You will see more than 40 or more oral preparations of
iron.
Some have intrinsic factors, and some vitamins
such as folic acid. There is no advantage to these
additions. The simplest and bestipreparation is ferrous
sulfate.

C.

Iron preparations affect a blood test, especially
billirubin.
Iron dextran gives falsely positive
results.

D.

Iron darkens the urine, due to the sulfide.

E.

Iron dextran is given intravenously. This route is
safer than intramuscular.
It is given in a dose of
500 mg, by slow administration.

F.

Some drugs inhibit absorption of iron from the gastrointestinal tract. There antacids, tetracycline,
vitamin E, pancreatic extract and penicillimine.

G.

Coated tablets decrease the absorption of iron because
the best site for absorption of iron is the upper
gastrointestinal tract (43, 45, 47, 48).
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Instructions for the Patient
A.

The oral iron pr~paration should be taken with a full
glass of water 1 hour before meals or two hours after
meals.

B.

If there is nausea or vomiting,
aration during the meal.

C.

If you use an antacid, be sure that you do not take it
with iron because antacids decrease absorption. ·

D.

Keep out of the reach of children. As acute poisoning
is very common. One dose of the medication may be toxic
to your child.

E.

Tetracycline will decrease absorption of iron.·

F.

Do not miss any dose as it will contribute to the failure
of the treatment (48, 49).

take the oral prep-

Chapter 7
RHEUMATOID ARTHRITIS
There are several rheumatic diseases.

These are rheu-

matoid arthritis, osteoarthritis, gout, ankylosing spondylitis, palymyalgia, vasculitis, rheumatic fever, juvenile
chronic polyarthritis, and others (51).

In the following

pages rheumatic arthritis will be discussed as an example
of rheumatic disease.
Rheumatic arthritis is considered a chronic disease
of unknown causes (52).

This disease is evidenced by inflam-

mation of one or more of the joints.

It usually begins with

simple inflammation, becoming warm and swollen.

If the

disease progresses it can cause development of granulation
tissues, called pannus formation.

This granulation begins

to destroy the articular

catising pain and erosion

of the cartilage.

~artilage

The surface of the cartilage is converted

from a smooth surface to a rough one, leading to subluxation
or dislocation of the joint.

The late stage is charac-

terized by ankylosis (rigidity of the

joint),:~Which

leads

to deformities (52).
Some of the signs and symptoms of rheumatoid arthritis
are fatigue and muscle weakness, swollen joints which may
be symmetrical, limitation of joint movement or motion,
prolonged morning stiffness, and difficulty in walking.
Also an increased incidence of colds with low grade fever.
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Rheumatoid arthritis is classified into three categories, dependent on diagnostic criteria.

Classical rheuma-

toid arthritis, definite rheumatoid arthritis, and probable
rheumatoid arthritis.

Those diagnostic criteria include:

a)

the patient may have morning stiffness.

b)

the patient feels pain and he finds that motion
is very difficult.

c)

the patient notices swelling in at least one joint.

d)

x-ray findings are positive.

e)

rheumatoid factors are positive.

f)

histological change in nodules or in the synovial
fluid.

g)

subcutaneous nodules are present.

It is considered as clinical if most of these symptoms are
found in one patient (51, 52).

Rheumatoid arthritis is

limited to the joints, and is more common in women than in
IIJ.en.
The blood analysis of rheumatic patients is characterized by these findings:
a)

the red blood cells are normocytic hypochromic.

b)

the serum of the patient will show a deficiency in
iron concentration.

c)

the white blood cell count will be elevated.

d)~.the

e)

erythrocyte sedimentation rate is elevated.

the blood protein, especially globulin, is elevated
due to increasing synthesis of antibodies IgG,
IgM, and IgA.
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The diagnosis of the disorder partly depends on the
results of laboratory tests such as:
a)

those which measure the erythrocyte sedimentation
Tate.

b)

serological test, looking for rheumatic factors
or antinuclear antibodies.

c)

X-ray findings.

d)

analysis of the synovial fluid.

Rheumatoid arthritis is a very dangerous disorder especially
if it progresses.

There are some extra articular manifes-

tations of this disease.
a)

Those manifestations are:

anemia (normocytic hypochromic anemia).

It is

considered the most active manifestation of rheumatoid arthritis.
b)

rheumatoid nodules--They are located on the surface
of elbows or the external surface of the fingers.
These nodules may breakdown and cause the drainage
of fluid and become the spot of infection.

c)

nail-fold-thrombi--This may lead to gangrene as
well as ulceration.

d)

pulmonary fibrosis--This is characterized by interstitial fibrosis! and nodules in the parenchyma.

e)

pericarditis, splenomegaly, and lymphoadenopathy
are involved in the late manifestation of rheumatoid arthritis.
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What to do if you have Rheumatoid Arthritis
1.

The earlier you begin treatment, the more benefit
you Will-'get from it.

2.

It is important to know a little bit about this disease
to build a positive attitude regarding this disease.

3.

The physical therapy including training procedures and
the use of heat can help to relieve pain.

4.

Be aware of possibility ofdeveJ:oping anemia.

5.

The treatments by medications are important, and remember those drugs, which are usually used.

6.

Maybe tha_doctor will prescribe to you corticosteroid
or gold salts or penicillamine.

7.

Surgery may be done if needed.
The treatment of rheumatoid arthritis depends on the
stage of the disease and the response to the medications.
There are several lines which the physi(cian must follow.

The fist line of treatment:
Aspirin in large doses.

Second line of treatment:
A rapid-acting ilion-steroid anti-inflammatory such as
Ibuprofen Naproxen Fenoprofen Tolmetin Sulindac -

(Mortin)
(Naprosyn)
(Nalfon)
(Tolectin)
(Clinoril)

Third line of treatment:
Slow-acting non-steroid anti-inflammatory such as:
Indomethacin '
Phanylbutazone
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Fourth line of treatment:
1.
2.
3.
4.

Gold Salts
Penicillamine
Anti-Malaria drugs
Immune suppressives such as
a) cyclophosphamide
b) azathioprine

Corticosteroids:
1.
2.
3.

orally
ACTH injection
intra-articular injection (51)

The first line of therapy is aspirin.
which the physician usually prescribes.

It is the drug

The physician

usually does not go to another drug until there is no response
to the aspirin or side effects of the drug appear.
is acetylsalicylic acid.

It is a weak organic acid.

Aspirin
It

has antipyretic analgesic and anti-inflammatory properties.
The lower doses of aspirin do not produce anti-inflammatory
action as do large ones.

Aspirin is absorbed directly from

the stomach and upper intestinal tracts, being distributed
throughout the body.

It will pass through the placenta (53).

Aspirin also is found in the cerebral spinal fluid.
bound to the blood protein especially albumin.

It is

Its excre-

tion in the urine is influenced especially by the pH level
of the urine.

The clearance of aspirin increasing if the

urine is alkaline.
The major side effects of aspirin are headache, dizziness, tinnitus, gastric irritation, gastrointestinal bleeding, and ulceration, (especially peptic).

The platelet
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aggregation is decreased and may cause a bleeding disorder.
There may be a hearing loss due to chronic use of aspirin (54).
There are no differences or advantages to using one
brand of aspirin over another or from using the buffered
kind, if you take aspirin with large amounts of water or
after eating meat.

All of the brands contain aspirin and

vary in their other additives.

Bufferin contains 480 mg of

aspirin with buffered aluminum glycinate and mg carbonate.
Excedrin contains aspirin (280 mg) plus acetaminophen
(250 mg), and caffeine (65 mg).

APC is aspirin, phenacetin,

and caffeine, and it is not recommended.
The other medications are non-steroid anti-inflammatory
such as phenylbutazone (Butazolidin) and oxyphenylbutazone
(Tanderil).

They are effective in reducing the synovitis

of active rheumatoid disease.

It hsould be used in short

term therapy only because of side effects such as salt retention, peptic ulceration, rashes, and also hematologic abnormalities and disorders.
cin).

Another drug is indomethacin (Indo-

It has major side effects which are headache, confu-

sion, and peptic ulceration.

If neither the aspirin nor the

non-steroid anti-inflammatory (such as phenylbutazone or
indomethacin) is effective fail, the gold salts may be
used (55).
The preparations of gold salts are:

sold sodium thio-

sulfate, gold sodium thiomalate, gold thioglucose, and gold
thioglyconate ..

However, these can have side effects or

cause adverse reactions, such as skin rash.

Corticosteroids
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may be used as systemic administration or topically, but
they have contraindications and may cause adverse reactions
such as depressed immune response (51).
In Saudi Arabia, most medication can be obtained without
~

F'i

a prescription except narcotics and tranquilizers.
causes a major'problem among the population.

This

This problem

may cause drug-drug interactions.

for headache or arthritis is very common.

The major drug

interactions of aspirin and other drugs are:
1.

Alcohol causes gastrointestinal irritation.

Aspirin

with alcohol increases the risk of ulceration.
2.

Aminosalicylic acid potentiates aspirin and causes

salicylism.
3.

Ammonium chloride increases the salicylate level

due to the decreasing of the clearance.
4.

Ascorbic acid (Vitamin C) will increase the plasma

level of aspirin.
5.

An anticoagulent such as Warfarin of which the

major side effect is gastrointestinal bleeding and the use
of aspirin will increase the risk of hemorrhage.
6.

Aspirin will increase the effect of oral antihyper-

glycemic agents and may cause hypoglycemia.
7.

Aspirin is to be avoided in the presence of gout

because aspirin will increase the uric acid level (57).

----
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Instructions to the Pharmacist

1.

Aspirin is hydrolized to acetic acid and salicylic
acid when moist.
Remove the product from your pharmacy
if you notice an odor of acetic acid.

2.

Aspirin is not recommended for an infant under one year.

3.

Aspirin is used with caution in a patient with renal
impairment.

-------4-.-Be sure you unders-tana-tnedrug=Tnt-eract-ion oTa-spfr1n
as there is a high chance o~ interactions.
5.

Aspirin interferes with the lab measurement of uric acid.

6.

Avoid dispensing phenylbutazone to a patient with
congestive heart failure.

7.

A patient who is taking phenylbutazone should be warned
to report any abdominal pain, fever, rashes, or swelling
of the ankles.

8.

The treatment of the toxicity of phenylbutazone is by
emptying the stomach and by giving sodium bicarbonate.

9.

All of these medications must be protected from light.

10.

There are now medications which are non-steroid antiinflammatories. They have less side effects, but they
sho"uld not be used until there is aspirin failure.

11.

Be aware about the widespread availability of corticosteroids (53).
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Instructions for the Patient

1.

Aspirin may cause peptic ulcer and gastrointest~nal
bleeding. Take aspirin after meals and drink water
with it.

2.

If you drink alcohol, do not take aspirin with it
because there is high risk of gastrointestinal bleeding.

----'3-.-Bo-not-mi-x-an-t-ac-:tds-wi:th-aspi:ri:n--,-as-t-hey decrease
aspirin''S effectiveness.

the-----~

4.

If you are a diabetic person and you are taking an
oral hypoglycemic, do not take aspirin because aspirin
may increase the hypoglycemic effect of these agents.

5.

Tell your doctor about any extra medications· you are
using.

6.

Aspirin is contraindicated in pregnancy, gastric ulcer,
or any bleeding of the gastrointestinal tract.

7.

Do not prescribe aspirin for yourself to treat arthritis.
You could, for example, have gout and aspirin
would be contraindicated.

8.

Be aware if you take phenylbutazone.
It must be used
for a short period of time, and it should be taken
after meals.

9.

Avoid indomethacin (Indocin) if you are taking an
antipleptic drug.

10.

Avoid taking aspirin, indomethacin or phenylbutazone
if you have a peptic ulcer, or bleeding.

11.

There are always new drugs, so be sure that you are
informed about your medications and report any difficulties to your doctor.

12.

Keep all medications out of the reach of children.

13.

Always report medications, symptoms and complications
to your doctor.

Chapter 8
DIABETES MELLITUS IN ADULTS
----

Diabetes mellitus is a chronic disease characterized
by a disorder of the metabolism of carbohydrates, protein,
and fat.

Diabetes is associated with hyperglycemia due to

the absolute absence of insulin or the reducflon-01-fheeffectiveness of insulin.

These are two types of diabetes:

the juvenile onset and adult onset diabetes (58).

The normal

metabolism of carbohydrates, fat, and protein, however,
should be discussed bef6re the discussion of abnormal metabolism.

After the normal person (non-diabetic) digests and

absorbs sugar, the glucose goes into the circulation through
the influence of the insulin which is secreted from the
pancreas.

It is utilized in different areas of the body

excluding the brain, which utilizes glucose without the
need for insulin.

Insulin converts glucose to glycogen in

the liver and the muscles; it increases glucose intake across
muscle cells; it increases glucose utilization via the Krebs
cycle in order to produce energy; it decreases the breakdown
to the amino acids and the fatty acids to glucose; additionalLy, it increases the synthesis of fatty acids and
triglycerides.

Insulin increases glycogen synthesis and

decreases other catabolic processes such as glycogenolysis,
ketoacidosis, gluconeugenesis.
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If the person does not eat, there is no exogenous sugar
in the blood and the glycogen in the liver is converted to
glucose.

At the same time, the other mechanism, such as

gluconeogenesis (synthesis of glucose from amino acids or
another source rather than carbohydrates), has begun.

Lack

of glucose causes wasting the muscle, fat, and protein, and
the body depends on its own storage of glycogen, protein,
--------an-d-fat----to-pro-d u-c-e-glutm_s_e_;--an--<:rssen t-ial- s-ource -crf -ene-rgy-: -------- ---In. the diabetic patient, there is glucose in the blood
which cannot be utilized and the mechanisms upon which the
fasting person depends to produce glucose are activated.
Accumulation of blood-glucose (hyperglycemia) is responsible
for many of the symptoms of diabetes (59).
The major symptoms of diabetes are weakness, fatigue,
weight loss, and polyuria, polydipsia, and polyhagia.

Also,

the diabetic may experience blurred vision, pain, muscle
cramps, intensive itching, and slow wound healing.
The following table is a comparison between the two
types of diabetes mentioned earlier:

juvenile onset and

adult onset (60).

Juvenile Onset Diabetes

Adult Onset Diabetes

Insulin dependent

Insulin independent

Ketosis prone

Ketosis resistant

Hyperosmolor resistant

Hyperosmolor prone

Rapid onset

Gradual onset
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Juvenile Onset Diabetes

Adult Onset Diabetes

Rapid onset

Gradual onset

More severe

Less severe

Greater insulin deficiency

Normal insulin, or higher
than normal

Patient is thin

Obese patient

Diet alone in inadequate
No response to oral
hypoglycemic agents

____ Q!~~~_a_y_}:)_e_

~d~gu~_!~ _________

Oral hypoglycemic agents
are effective (59).

The diagnosis of diabetes is based upon clinical tests.
The diagnostic test is the oral glucose tolerance test.
This test depends on determining the fasting blood sugar
level two hours after administering 100 mg of glucose.

If

a

the person is non-diabetic, the blood sugar returns to
normal level within two hours after glucose loading.

If

the patient is diabetic he needs more time to return to
normal.

There are a number of other tests for screening

and aids to diagnose, such as testing for glucose in the
urine, or 2 hour postprandial blood sugar (58).
If the person does not begin treatment for diabetes,
there may be many complications associated with increasing
blood sugar level.

There are some complications which are

acute, such as ketoacidosis and non-ketotic hyperosmolor
coma.
The later complications are increased tendency ror
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myocardial infarction, congestive heart failure, tendency
to myocardial rupture, and increase in the risk and severity
of coronary artery diseases.

Patients with diabetes are

more liable to coronary disease than non-diabetics.

Dia-

betics also may have decreased or lack of circulation in the
extremities, particularly the feet, which may lead to gangrene.

High blood sugar level increases the tendency to
- - - - - -

cerebral vascular accident and hemorrhage.

A change in the

metabolism of lipoprotein leads to the increase of the total
lipid and cholesterol, and a decreaseof triglyceride clearance, which lead to hypercholesterimia hyperlipidemia, a
condition closely associated with atherosclerosis.
Second, diabetes affects the retina in the eye, causing
a chronic progressive disease which may lead to blindness.
Diabetes is considered the most important systemic disease
which causes blindness.
Third, nephropathy is another dangerous complication
which can lead to death due to kidney failure.

In this case,

there is glomerulosclerosis and a hyaline mass in the
glomeruli.

Also, there may be glomerulosclerosis which is

characterized by glomerular basement membrane thickening.
As a result, this causes diabetic glomerulosclerosis of the
nodular or diffuse varieties of arterial and arteriolar
nephrosclerotic pyelonephrytis.

The first clinical pictures

are porteinuria, edema, azotemia, and also hypertension.
first sign of nephropathy is edema.

There is a possibility

of silent myocardial infarction, papillary necrosis, and
infections. (61).

The
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In general, the management of diabetes is the balance
between diet, exercise and

ther~py.

independent diabetes is the keystone.

The diet in insulinDiet is considered

the first step to control diabetes in obese patients.

If

the patient reduces his weight and the blood sugar is not
controlled, other treatments must be initiated.

When the

symptoms of the disease are adequately controlled by reduc---·-·-tn-g-wc:ri-gn-t-an-d--the----regunrtron.·-<Yf-the-diet--;-··-no Otlfer -tne-rapy______ - --is indicated, but if the obese patient cannot control his
weight, then oral hypoglycemic agents or probably insulin
is required.

The diet adjustment must depend on several

variables which include the kind and amount of physical
activities, occupation activity, body weight, race, and
other factors.

The diet is calculated on the amount of

calories required.

A maintenance diet is calculated by

multiplying the patient's weight in kilograms by 30, a reducing diet is calculated by multiplying the body weight in
kilograms by 20 which will give the ·daily caloric intake.
The ideal diet is composed of 40% carbohydrates, 20%
protein, and 20% fat.

These percentages need to be modi-

fied upon if there is liver disease, renal disease, and
excess body weight.

The daily food intake should be divided

into five or more meals instead of three meals.
intake of unsaturated fats should be reduced.

Also, the
A vitamin

supplement is required, especially in older people and for
those consuming a malnutritional diet (62).
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The second step of management, if diet alone does not
control the blood sugar level, is the use of oral hypoglycemic agent.

These agents are the sulfonylureas.

They act

as stimulants to release insulin from the pancreas, and
also they may enhance the effectiveness of insulin at the
receptor sites.

They also increase the affinity of insulin

for the receptor site.
--------------,o~n"'s~e=t-diabetes

Sulfonylureas are used in adult

.--Thoseagents wfli-cli afe--usuaTiy- use-d-are----------

listed in the following table (63).
Oral hypoglycemics have an advantage in that they are
easy to use, and also they are good for the non-insulin
dependent patient, and they stimulate the release of endogenous insulin.

The disadvantage is dependence upon the

patient to monitor himself when using these agents.

There

may be some adverse reactions.
The first adverse reaction is hypoglycemia.

This is a

clinical conditon associated with a low level of glucose in
the blood.

During hypoglycemia the glucose blood level is

less than 50mgjl00ml.

The symptoms and signs of hypoglycemia

are feelings of fatigue, heaviness, a tremor in the hands,
confusion, nervousness, and sometimes delusions.

The usual

causes of hypoglycemia are due to:
a)

dietary changes or inadequate nutrition

b)

weight reduction, and the same time using the
same doses of oral hypoglycemic.

c)

increasing physical activity above the normal
level

AGENT

DURATION

DOSE

FREQUENCY

TABLETS OR
.CAPSULES

PHARMAC~LOGICAL

COMMENTS

COMMEjNTS

I
Tolbutamide
(Orinase)

8 hours

10003000 mg

2 x a day
or
3 x a day

500 mg

.

.I

drug of choice

1.nac t1.1ve
metabollic
producits
excret ed
1

I

Acetohexamide
(Dyroelor)

12-24 hrs. 500-1500
mg

once da:Uy
or 2 x a
day

250 mg and
500 mg

II

metabo'lic prod uct I.S
.I more
potent! as a
hypoglycemic
effecti than
the or~ginal

the second choice
or alternative
to Orinase

(j)

I

I

Tolazamide
(Tolinase)

16-24 hrs. 100-1000
mg

once daily
or 2 x a
day

100-250 mg

I

has 6 inetabolite p!roducts

intermediate
duration of
action

I
I
I

Chlorpropamide
(Diabinese)

24-36 hrs

125-500
mg

once daily

100-250 mg

I

excretion

avoid in renal
disease and
elderly people

unchan!.~ed

I

'Il

I-'

0

I

I

!·-I
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d)

removal of stress, emotional stress or the stress
due to a surgical operation

e)

termination of a pregnancy

f)

correction of hyperendocrinopathy such as Cushing
Syndrome

g)

omission of meals, or forgetting to take a meal.

There are many factors associated with hypoglycemia
----------au~o

orarll.ypog-rycemrc- agerfts-.--Tnese-factors -rncl uae Tna-p---------- ·

propriate dosage, a person uses more of the medication than
is required, impaired renal functions leading to a prolonged
hypoglycemic effect, or by administration of other drugs,
which exacerbate the

hypogly~emic

effects.

Also, if the

hypoglycemia appears, sometimes syrups, juice, or milk may
reverse the situation.

The patient may require intravenous

hypertonic glucose solution for severe hypoglycemia (58).
There are many drugs which interact with the oral
hypoglycemic agents.

There are those drugs which may increase

the effect and drugs which may reduce the effect leading to
hyperglycemia.

Anabolic steroids alone may decrease blood

glucose level in some diabetes patients.
hypoglycemic response to tolbutamide.

It increases the

Chloramphenical

inhibits hepatic microsomal enzymes activity, the result is
an increase in the half life of oral hypoglycemic agents and
an

i~crease

in the activity of the hypoglycemic effect.

Also,

monoamine oxidase inhibition interferes with compensatory
adrenergic response to hypoglycemic agents.
prolongs the hypoglycemic response.

It enhances or

Phenylbutazone prolongs
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the half life of the active metabolite of chlorpropamide and
enhances the hypoglycemic response.

Probenicid will inhibit

the renal tubular secretion of chlorpropamide and enhances
the hypoglycemic effect.
On the other hand, alcohol, salicylates, thiazide
diuretics, glucagon, epinephrine, and oral contraceptives
antagonize the effect of hypoglycemic agents indirectly and
may cause liyperglycemia-:-_______ --- ----------------- ----------- -----------

Instructions to the Pharmacist

1.

Oral agents should not be given until the patient knows
how to balance a diet and exercise, and after the failure
of the diet alone.

2.

Oral agents are contraindicated in a history of ketoacidosis and insulin dependent cases. Also it is contraindicated with oral contraceptives.

3.

The patient who is sensitive to sulfa drugs may be
allergic to sulfonylureas.

4.

Hypoglycemic side effects of oral agents are rare, but
it may happen.

5.

If oral hypoglycemic agents and the diet combination
fails, the next step is insulin therapy.

6.

Alcohol and oral hypoglycemic agents are contraindicated
because alcohol and oral agents produce an antibuselike reaction.

7.

Alcohol increases the glucose level and causes hyperglycemia. It decreases the effect of the oral hypoglycemic agents (63).
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Instructions to the Patient

1.
2.

Your medication will not work if you exceed your recommended diet by eating too much starch or carbohydrates.
You must completely avoid table sugar, dates, and candy.

If you take rich foods (nutritional food) you do not
need to take vitamins unless your doctor recommends
____________ i_t_.
----------------------- -------------3.

4.

Salt should not be restricted from your diet except
for other conditions which need salt restriction.

5.

Remember the fact that your diet should contain protein,
fat, and carbohydrates· (a complete nutritional diet).

6.

It is recommended to eat on a regular schedule. Make
.a table of times and follow the schedule carefully.

7.

Do not hinder your social life by refusing invitations
to parties or dinners; go, but remember that.you must
choose the foods which are good for you.

8.

To be safe, follow the diet strictly at all times.

9.

If you are doing more exercise, it is recommended to
eat more snacks.

10.

Remember that oral hypoglycemic agents may have adverse
reactions, and if this happens see your doctor.

12.

Take care and clean your feet, and do not wear tight
shoes; be careful of your feet and protect them from
injury or infections.

13.

Visit your opthamologist regularly to take care of your
eyes.

14.

Remember that you must continue to take your medication,
all of your life (62, 63, 64).

~

Chapter 9

ESSENTIAL HYBERTENSION
-----

s

Hypertension occurs when the diastolic arterial blood
pressure rises above 105mmHg.

Age, sex, race, and environ-

ment are important factors in the etiology of hypertension.
The mortality can be reduced by adequate therapy.

It is a

chronic disease that requires treatment all of the patient's
life.

There is no known cure for this disease.
There are many factors associated with the increase in

risk, as well as being considered precipitating causes for
hypertension, such as age, obesity, smoking, high cholesterol levels, and race.

The cause of essential hypertension

is unknown; but the family history and race play a role in
this disease (65).
The signs and symptoms of hypertension vary from one
person to another.

There may be no overt symptoms and the

disease may be identified only by physical examination.
Other patients may have symptoms which indicate an elevation
of blood pressure, hypertension vascular disease or underlying diseases.

The symptoms may include headache (espe-

cially in the occipital region), dizziness, palpitation,
and fatigue.

Also, there are symptoms related to vascular

disease which include epistaxis, hematurea, blurred vision,
angina pectoris, and dyspnea.

If untreated it may lead to

heart failure, polyuria, polydipsia, and muscle weakness
110
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which are secondary to hypokalemea.
The diagnosis depends on the symptoms seen, the blood
pressure and the laboratory tests which include:

a urine

test for protein, a blood test for glucose, hematocrite serum
potassium, serum createnine, blood urea nitrogen, and an
electrocardiogram test for irregularities.
The goal of treatment of hypertension is to maintain
________b_l_o_o_d-pr-es-sur-e-in_t_h_e_n_o-rm-al-r-ange- level- and-to- aec-::rease -t:ne-- ----mortality associated with rising pressure (65).

The first

general method of treatment is weight reduction.

It is very

important to reduce the weight because it is a major risk
factor (66).

The second step is sodium restriction.

The

amount of sodium chloride ingested must not exceed 4-6gm.
per day.

The third step is improving the physical condition,

especially by isometric exercises such as running.

The

physical activity will both reduce body weight and lower the
blood pressure (65).

The fourth step is removing the physio-

logical stresses and remembering that tension and anxiety
will only raise the blood pressure (66).
After all of the above, drug treatment is the next
step.

The therapy is usually begun with diuretics.

The

drug therapy is very important because the anti-hypertensive
affect reduces the risk of hypertension complications, such
as congestive heart failure, stroke, and renal damage (67).
The complications of untreated hypertension are numerous,
but the most important of them is hypertension encephalopathy.

The clinical picture is headache, nausea, mental
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confusion, stupor, convulsions, and death if it is not
treated.

There may also be edema and thrombi in the brain

if this condition is not treated.

Hypertension can be

complicated by hemorrhageic stroke, cerebrovascular insuffi~iency,

and acute left ventricular failure (66).

It is important to begin treatment early to manage high
blood pressure.
-------n-i uret-ics are
sion.

The first step is the use of diuretics.

used-in-miTd~-rnode-rate-; anaseve:6~-liype:flen..::---------

Sometimes the diuretics and salt restriction is enough

for some patients.

Diuretics produce a negative salt and

water balance by preventing sodium retention.

Since the

anti-hypertensive effect of diuretics depends on adequate
natriuresis, the effect could be reduced or abolished by
excessive sodium intake, or by reducing the glomerular filtration.

Diuretics are of different types, classified by

the site they effect:

the filtration diuretics, such_as

cardiac glycosides, proximal tubular diuretics, such as
osmotic agents, and carbonic anhydrase inhibitors.

A loop

diuretic such as furosemide prevents the reabsorption of
sodium.

Aldacton (spironolactone) acts directly on the

sodium pump and decreases aldosterone production.

Thiazide

has a diuretic effect and inhibits sodium reabsorption
causing saluresis, which produces hyponatremia.

Thiazides

decrease calcium clearance, causing hypercalcemia, and
decrease uric acid clearance, causing hyperuricemia.

Thia-

zide also decreases creatinine clearance which causes
azotemia.

Also thiazide causes hypokalemea as well which
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leads to hyperglycemea.

Aldactone, a potassium sparing agent,

does not produce the above side effects, but may cause
amenorrheia in women and may cause gynecomastia in men.
Thiazide diuretics should not be used in renal function impairment and the drug of choice is furosemide (Lasix).
It is a potent diuretic which blocks chloride reabsorption
in the ascending limb of the loop of the Henal in the patient
wrtn renal-fa11 ur e ( 6T)-.
-- --- -- ---- ------~------~

~-----

----~

-~ ~-~-~--- ---------~-~--~--~

The second step involves beta-blocking agents such as
propranol (Inderal).

Some claim that propranol can be used

as the first drug, but the combination of diuretics and
beta-blockers just is more effective.

Propranol will

inhibit renin activity and reduces cardic output.

Beta-

blocking agents such as propranol are contraindicated in
person with asthma.

Also, beta-blockers must never be given

to a patient without first ascertaining that there is no
tendency for heart failure, or second degree heart block (68).
The second step includes the sympatholytic agents (sympathetic depressants) such as methyldopa (Aldomet) which forms
false transmitter a-methyl noradrenaline and causes some
depletion of axonal stores of noradrenaline and has some
adrenergic neuron.e blocking action.

Major side effects of

methyldopa are fever, a positive Coombe test, and also may
induce hepatotoxicity (hepatitis) and rarely hemolytic
anemia.

The adverse effects of methyldopa are sedation,

fatigue, dry mouth, and salt and water retention, and sexual
dysfunction (67).
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Another drug is reserpine.
mines and serotonin.

It depletes the catechola-

It causes peptic ulcer, depression,

nasal congestion, and possibly breast cancer (70).
Clonidine (sympathetic inhibitor) reduces sympathetic
outflow by stimulating a-adrenoreceptors.

Adverse reactions

to this drug are sedation, dry mouth, salt and water retention, sexual dysfunction, bradycardia, heart block and with-

which depletes axonal stores of noradrenaline and prevents
storage and release of catecholamines.

It has adverse

reactions such as orthostatic hypotension, sexual dysfunction,
diarrhea, salt and water retention, and intestinal cramping.
Step three is arteriolar vasodilation.

The vasodilators

which are used are hydralazine, prazosin, diazoxide and
nitroprusside.

Hydralazine reduces blood pressure through

direct relaxation of arteriolar smooth muscle.

Adverse

effects of hydralazine are related to the reflex sympathetic
stimulation or its direct vasodilation.

These include

headache, flushing, nasal congestion and dizziness.
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Instructions to the Pharmacist

1.

Diuretics must be given in.an adequate and standard
dose to achieve the effect.

2.

It is not used if the glumorulor filtration rate is
less than 35 ml.

3. If there is no response to diuretics there are two
_possible reasons wh_y not_:_____
_______________ _
a) vasoconstrictive type hypertension rather than
volume dependent
b) the diuretic does not induce adequate sodium
diureses.
4.

Diuretic therapy may cause hypokalemia. The patient may
need a potassium supplement. The pharmacist should
advise the patient to take food rich in potassium.

5.

If the patient is taking aldactone, no potassium sup-plement is needed, because it is potassium sparing (68).

6.

Restriction of sodium is important because excessive,
sodium intake renders the effect of diuretics useless.

7.

Thiazide causes hyperglycemia. It may be due to inhibition of insulin or due to hypokalemia. The patient
who takes oral hypoglycemic with thiazide should be
monitored carefully.

8.

Thiazide interferes with many blood tests such as uric
acid, amylase, blood ammonia.

9.

Thiazide may cause hypokalemia if the patient also takes
digitalis; the possibility of digitalis toxicity may be
enhanced ( 69) .

10.

Inderal iB- contraindicated-in asthma because inderal
has brohchoconstriction and aggrevates the asthma.

11.

There are drug interactions between inderal and aminophylline.

12.

Antacids such as sluminum hydroxide inhibit absorption
of inderal.
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Instructions to the Pharmacists (continued)

13.

Digitalis and inderal may aggravate each other, and
produce bradycardia.

14.

Barbiturates and phenytoin induce microsomal enzymes
and enhance the metabolism of inderal.

15.

Phenytoin and inderal may increase the effect (synergis
effect) and may depress the myocardium.

16.

A combination of two drugs with the same class and the
same mechanism may aggravate the side effects and
there will be no significant effect, for example,
guanethidine plus reserpine.

17.

Tricyclic interferes with the guanethidine effect by
blocking its uptake to adrenergic neurons.

18.

Anesthesia, procainamide, quinidine, or inderal exaggerate the lowered blood pressure induced by specific
antihypertensives (69).

---~
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Instructions to the Patient (68, 69, 70)

1.

Continue your medication and do not miss any day.
Report any side effects to your physician.

2.

Drug therapy can make a difference and that can save
your life.

3.

Remember there is no ideal drug for hypertension. Each
one may produce sid~E3JJ~Q_t§l. __RE:lPQI'_t_th_e_se __t_o -~our ______
--doctor.-------------

4.

Diuretics increase the excretion of sodium, so sodium
intake must be restricted.

5.

You must eat food rich in potassium as diuretics will
decrease your potassium level.

6.

If there is reserpine in your medication it may cause
peptic ulcer. Do not exceed the dose which is recommended to you.

7.

Remember that taking of clonidine should not be discontinued suddenly, as it can cause a withdrawal
syndrome.

8.

The first dose of prazosin may cause syncope. This
is an episode of sudden collapse and unconsciousness
which can occur in the patient taking 2 mg or more
for the first time.

9.

Begin a quiet life far away from those factors which
aggravate your problem. Stop smoking if you do, and
reduce your weight if you are overweight.

Chapter 10
GRAND MAL EPILEPSY
Epilepsy itself is not considered a disease.

It is a

sign of other diseases or an alteration of physiological
reactions of the central nervous system function.
- - - - - ------

-----------

---------

----

---

--

-

--

-----

The sei-----

- - - - - - - - - - - - - - - - - - - - - - --

zure is considered a sudden change of the central nervous
system due to a paroxysmal high frequency or synchronous low
frequency, or a high voltage electrical discharge.
The signs and symptoms of seizures depends on how the
seizure originated or which region of the brain is involved.
The seizure by conduction mechanism spreads to the brain-stem
center which controls the spinal motor neurons, then moves
to involve all of the brain.
involved as well and

th~

The autonomic system is

influence of this system in the

body appears such as dilation of

pupil~,

salivation, etc.

After seizures continue, the tonic muscular activity changes
or progresses to clonic movement.

Then the patient falls

into a coma, followed by confusion and lethargy eventually
returning to a normal state slowly (71).
Grand mal epilepsy is characterized by four phases.
The first phase is the prodomal phase; this is the aura
phase in which the patient is aware of remembering past
experiences, strange visual sensations, migraine headache,
crying, and seeing or pointing to something.
phase is the tonic phase.

The second

This phase is characterized by
118

119

muscle rigidity, and the airway is closed off by the vocal
cord causing an epileptic cry.
clonic phase.

The third phase is the

The convulsion is generalized with a tonic-

clonic spasm of. the extremities.

The last phase is the '
f'j'

postictal or relaxation phase in which the patient may
sleep several hours and wake up with a headache, and sometimes a sore tongue.
1n-:nls

And, also the patient may have urinated

cio'Clies~-nfs51adaer-having

or during sleep.

emptied during the seizure

Due to the stimulation of the autonomic

nervous system the patient is bathed in sweat, the pupils
of the eye

~re

constricted, and there is salivation and

foaming of the mouth accompanied by respiratory difficulties
(71, 72).

The causes of epilepsy, in a general statement, is
idiopathic, but there are some suggestions of causes leading
to the convulsions.

Some are severe perinatal injury

(especially in the newborn).

Metabolic defects such as

acidosis, alkalosis, congenital malformations, infections,
genetic disease, myoclonic syndrome, postnatal trauma,
brain tumor, vascular diseases, and myclonus epilepsy.
There is no clear proof that epilepsy is inherited, but the
evidence for inheritance is strong if the patient's seizures
start at an early age (71).

Diagnosis of epilepsy depends

on clinical manifestations, family history, signs and
symptoms, an EEG to determine if there is a brain tumor,
a spinal puncture to study spinal fluid, and brain scan to
determine where the foci are (72).
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What to do for the patient who is in a convulsive
state:
1.

Put the patient in a wide place and away from hard
objects; put the patient in bed, or prevent the
patient from falling down.

2.

Put something in his mouth such as clothes, or a
hard thing between his jaws to prevent him from
biting his tongue.

3.

Put the patient on his side, and avoid putting the
patient on his back or on his abdomen because

----------------tnere-i-s-a-ch-ance-c}f-v-omi_t_i_trg-~---

------- ------------------------------

4.

Loosen his clothing to avoid choking.

5.

Do not give the patient his medication orally and
do not give him water or food .

. 6.
7.

Check the breathing. If the breathing has stopped,
give him artificial respir~tion.
Watch carefully and call an ambulance.

Grand mal epilepsy have regular intervals but the interval may be close enough that they occur more than once in
24 hours.

Status epilepticus needs emergency treatment and

medication by intravenous route is necessary for treatment.
The treatment goal is complete suppression of the
seizures, at a dose level which will produce this effect
without signs and symptoms of drug side effects or toxicity.
The drugs that are commonly used to treat grand mal epilepsy
include phenytoin (which is the drug of choice). Phenobarbital, primidone and carbamazepine are the alternatives.
Also, there are combinations of these drugs.

In the

ing tables the drugs commonly used with some of their
respective characteristics are listed (73).

follow~

Drugs that are used in the treatment of Grand Mal Epilepsy (73j
.

AGENT

ADULT
DOSE

BRAND NAME

CHILD
DOSE

SERUM
CONCENTRATION

HALF-LIFE

I

TIME 'I!'O
REACHITHE
PLATEAU

COMMENTS

I

Phenytoin
(PPH)

Dilantin

300-400
mg

4-7/
kg

10-20 Mg/
100ml

7-42 hrs

I

5-10 dlays

the drug of
choice

I

I

Phenobarbital Luminal
(PB)

150-250
mg

3-8/
kg

10-35
Mg/100 ml

2-4 days

alternative

14-21 ldays
I

Primidone

Mysoline

Carbamazepine Tegretol

'Ill

500-1500
mg

10-25/
kg

6-12
Mg/lOOml

3-12 hrs

600-1200
mg

15-30/
kg

6-8 Mg/
100 ml

7-30 hrs

I
4-7 days

f-1

alternative

l\j

f-1

I

2-4

d~ys

alternative

I

I
I

!.

:~1

I.

iL.
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When the patient is in status epilepticus, the intravenous route is used.

Intravenous diazepam is the drug of

choice often but sometimes phenytoin is preferred.

Phenytoin

has brand names such as dilantin, dilabid, ditiycon, and
dilan.

It has been used for forty years and still is the

most popular drug to treat grand mal epilepsy.

Ninety percent

(90%) of this drug is bound to protein and is metabolized in

the steady state is reached in four to five days.

It has

side effects such as ataxia, diplopia, vomiting, and hypersensitivity reactions such as skin rashes and fever.

Also,

phenytoin may produce liver dysfunction, such as hepatitis.
Also, chronic use may produce hypertrophy

of the gums.

It

causes folic acid deficiency with or without microcytic
anemia.

Also it interferes with Vitamin D metabolism with

thyroid functions.

It will also cause nystagmus (74, 75).

At blood level greater than 30 mgjml ataxia and dysarthria
can occur.

Additionally, Vitamin K level may be depressed

and bleeding disorders have been reported.

Phenytoin is

teratogenic which may cause congenital abnormalities (75).
Phenytoin has an affect on membrane cell stabilization.
It will stabilize the exciting membrane and prevent the
spread of the seizures.

It will reduce sodium and calcium

influx into the nerves and prevent post-tetanic potentiation
and post-tetanic hyperpolarization, as well as decreasing
the neurotransmitter from the nerve endings (77).
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The second drug is phenobarbital.

Phenobarbital is

used as an alternative to phenytoin, and it is a widely used
and effective drug.

It may be used in combination with

phenytoin and carbamazepine.

The side effects of pheno-~

<=j

barbital, or the unwanted effects, are sedation, nystagmus,
ataxia, and osteomalacia.

Also in young children, hyper-

activity or restlessness may occur.

Addiction to phenobar-

ability (76).
Phenobarbital is a potent anticonvulsant, more so than
other barbiturates.
with phenytoin.

There are some qualitative similarities

They block the sodium conduction, stabilize

the nerves, and decrease calcium influx into the depolarized
nerve endings.

It will depress the sympathetic transmission

at a number of different sites (71).
The third drug is primidone (mysoline) and it is also
effective in grand mal epilepsy.

It is absorbed quickly.

The half life is about 12 hours.

It is converted to two

active metabolites, which are phenobarbital and phenyl
ethylamalonamide.

The sdie effects include ataxia, nausea,

and irritability in children.

It is absorbed from the

stomach and the intestines and most of its effect is due to
its metabolite phenobarbital.

The most common side effect

is drowsiness and the mechanism of action is similar to
phenobarbital (76).
Finally, carbamezepine (Tegretol).

It is useful in

the treatment of generalized tonic-clonic seizures, but more

~
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effective especially in the treatment of partial seizure.
The drug has side effects including dizziness, ataxia, diplopia, drowsiness, impaired hepatic function, and bone marrow
suppression.

It is structurally related to the tricyclic

antidepressants (76), but its major effect is as an anticonvulsant.

The adverse effects include hepatitis, aplastic

anemia, heart block, ataxia, diplopia, and skin rash.
-------------I-t-i-s-vel'-y-impe-r"b-a-nt--to-know-the- drug- intera-ctions-with------- --

anticonvulsants.

The drugs which are used in grand mal epi-

lepsy are phenytoin, primidone, phenobarbital, and carbamazepine.

In

g~neral,

tricyclics may produce epileptic-form

seizures in susceptible patients and the patient must be monitored closely.

Also, oral contraceptives induce fluid reten-

tion and may precipitate seizures.

It is recommended that

epileptic patients use another birth control rather than an
oral contraceptive.

It is important to know this information

about phenytoin drug interactions, and also the complications
·of treatment and overdoses, and how to treat it (71, 78).
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Instructions to the Pharmacist

1. · Patients with epilepsy and glaucoma using acetazolamide
will have increased side effects of the anticonvulsant,
and osteomalacia may be induced.
2.

Alcohol enhances the metabolism of phenytoin and seizure
control is reduced.

3. Antihistamine preparations enhance the phenytoin plasma
_________ leY-el_and--mRy-inc!'-ease -toxici-ty. ----- ---- ---- -- -- - - - - 4.

Barbiturates induce microsomal enzymes and increase the
metabolism of phenytoin and the serum therapeutic level
is decreased.

5.

Benzodiazopines increase the blood level of phenytoin.

6.

Phenytoin enhances the metabolism of corticosteroids.

7.

Diazoxide enhances phenytoin metabolism.

8.

Phenytoin enhances the metabolism of digitalis.

9.

Folic acid, when given, will decrease the phenytoin level
in the blood and phenytoin will also cause folic acid
deficiency.

10.

In general, the basic drug interactions are due to alteration of absorption, interference with protein binding,
or with the metabolism.

11.

Acetazolamide reduces the gastrointestinal absorption of
primidone.

12.

Primidone is converted to two metabolites. Gving barbiturates plus metabolites will increase the blood level.

13.

Propoxyphene inhibits the metabolism of carbamazepine.

14.

Barbiturates stimulate the metabolism of carbamazepine.
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Instructions to the Patient

1.

Do not treat yourself by the ways or methods the public
describes to you.

2.

The treatments which are used in the hospital are the
ideal method for your problem.

3 .__ _Dg_ not_di_s_c_Qn_t_inue_ the _treatment for any --reason and- be- - careful not to take an overdose.
4.

Refill .your prescription before your medication is
finished and visit your physician regularly. Report
any side effects to your physician.
·

5.

It is recommended to avoid driving a public vehicle
or work with sharp or dangerous machines.

6.

Do not travel without enough medication.

7.

It is recommended when traveling that you take with you·
your certificate which shows that you are using the
medication legally.

8.

If you have an illness other than epilepsy and you need
to take another drug, tell your physician about your
medication to avoid drug interactions, or an alteration
of the serum level of your medication.

9.

Remember that you are not alone in this world, but
there are millions of people you you who have epilepsy
(73, 75, 78).

Chapter 11
GLAUCOMA
Glaucoma is most common in older people and is a very
I

complicated disease which needs very careful management.
Glaucoma is a chronic disease with multiple etiological
causes.

Sometimes glaucoma is asymptomatic and causes irre-

versible destruction of the visual field.

The treatment is

very important to prevent progression of the disease and
hence, loss

of' vision.

It should be detected early to begin

treatment, and the patient must continue using the medication
all of his life (79).
The definition of glaucoma is a rise in the intraocular
pressure of the eye.

Normally there is a constant production

of clear fluid within the front part of the eye, which is
drained away as fast as it is produced.

In glaucoma, there

is interference with the drainage of this fluid which leads
to increased pressure.

Thus, in glaucoma, there is an increase

in the intraocular pressure which leads to a change in the
optic disk and gradually a loss of the visual field.

This

increases the intraocular pressure due to obstruction to the
outflow of the aqueous humor.

The aqueous humor is produced

primarily in the cilinary body with drainage from the posterior
chamber via the pupil into the anterior chamber of the eye.
It discharges from the eye through the canal, called Schlemm,
at the angle of the eye, to the veins (80).
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In the following table are listed the types and kinds of
glaucoma.

This classification divides glaucoma into four

categories depending on the causes and characterizations of
each type.
;='!

I.

II.
--~-~-

-- -~-~-

Primary Glaucoma
1) Open angle glaucoma
2) low tension glaucoma
3) Primary closed angle glaucoma
Variants of Primary Glaucoma

-------1-)--P±gmentary~glaucoma

2)
III.

IV.

Foliation glaucoma

Devlopmental Glaucoma
1) Primary
2) Infantile
3) Glaucoma ·associated with heredity
Secondary Glaucoma
1) Inflammatory glaucoma
1. Ureitis of types
2) Phacogenic glaucoma
1. Angle closure with cataract
2. Phacoanophylactic glaucoma with rupture
of the lens
3) Glaucoma secondary to intraocular hemorrhages
1. Hypqema
2. Hemolytic glaucoma
4) Traumatic glaucoma
1. Traumatic recession of chamber
2. Post-surgical glaucoma
5) Drug induced glaucoma
1. Corticosteroids
2. Anticholinergic
6) Miscellaneous glaucoma
1. Tumor
2.
Chemical burns
3.
Irish ·atrophy

The symptoms

of glaucoma are various.

If the patient has

open angle glaucoma, there are no symptoms (Silent).
disease progresses slowly.

The

It may become advanced before the

patient recognizes it, but some indications such as the need
for changing glasses, mild eye aches, may indicate open angle
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glaucoma.

The second type which is characterized by severe

headache, pain, nausea, vomiting, and decreased visual activity,
halo and rainbow vision is an indication of closed angle
glaucoma (79, 80).
If the patient does not have glaucoma treated, the chronic
elevation of intraocular pressure will effect the nerve fibers
by influencing the vessels which supply the nerve fibers.
---------------I-nc-r-ea-s-i-n-g--t-he--p-F-essure--\V-i-11---cause ischemic -impairmen-t-- and--

reduce the nutrition supply, impair axoplasmic flow (protoplasm of the axon) and hence, gradual and irreversible destruction, leading to blindness.

The greater the rise in intraocular

pressure, the more serious the complications (79, 80).
There are three factors which influence the pressure::
the rate of aqueous production, the rate of aqueous outflow,
and the volume of other tissues within the eye.

There is

equilibrium under normal pressure but with glaucoma there is
no equilibrium.
21 mmHg.

The normal intraocular pressure is 12 to

The visual field diminishes. within five years in

3.5 percent of patients with intraocular pressure between
21 and 30 mmHg.

The more the ocular pressure increases, the

greater the risk for loss of vision (79).
The goal of the treatment of glaucoma is to reduce and
sustain the intraocular pressure in order to prevent deterioation of the optic nerve and loss of visual function.

The

drugs which are used are divided on the basis of mechanism of
action.

Some drugs cause an increase in the elimination of

aqueous humor; others decrease the production of aqueous
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humor.

The basis of treatment of glaucoma is:

A.

Increasing elimination of aqueous humor by a drainage
system.

Such drugs are parasympathomimetics and

sympathomimetics.

B.

Drugs which decrease the formation of aqueous humor
by the ciliary process.

Those drugs are sympatho-

mimetics and carbonic.anhydrase inhibitors.
------------------------G-.-- -'r-he-r-e--a-re--d-rugs--wh-ich -reduce---t-he- . vo-lume.
of --aqueou-s---------------

humor in the anterior chamber.

Those drugs

are

hyperosmotics, such as mannitol.
The drug therapy is to manage open angle glaucoma, but it
is necessary to use surgery for closed angle glaucoma (81).
The drugs which influence the outflow and increase the elimination of aqueous humor are parasympathomimetic drugs which
include direct acting cholingergics such as pilocarpine and
carbachol.

Also cholingeric Bsterase inhibitors such as

physostigmine (Eserine) and sympathomimetic agents such as
epinephrine.

Sometimes beta andrenergic blocking agents are

used such as Timoptic.

There are drugs which reduce the over-

production of aqueous humor, which are sympathetic, such as
epinephrine and carbonic anhydrase inhibitors, and Diamox
(acetazolamide).

Also, hyperosmotic agents, such as mannitol,

are given intravenously (32).
The medications are used essentially to treat open angle
glaucoma.

The medications are eye drops such as pilocarpine,

epinephrine, anticholingeric esterase, echothiophate iodine
drops, and demecarium bromide.

Also, systemic medication
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such as carbonic anhydrase inhibitors, e.g. Diamox (80).
The first line of treatment is a parasympathomimetic,
pilocarpine, for example, which have direct cholingeric effect.
Pilocarpine is considered the drug of choice.

It will increase

the elimination of aqueous humor, and induce miosis.

Pilo-

carpine causes contraction of the ciliary muscles and dilation
of the aqueous veins into which the schlemm canal empties.
'l'he-o~f-ie-ia-1-preparations

carpine nitrate.
ointment.

-are pilocarpine chloride-, and pilo-- ----

They are available in opthalmic drops and

The side effects and toxicity of pilocarpine are

due to the toxicity of the parasympathomimetic activity which
is treated with atropine (83).

Those drugs which include

pilocarpine and carbachol are called miotic agents (84).

The

other types from this class are cholinesterase inhibitors which
have miotic effect but are rarely used.

The following table

shows the characterizations of the two most important agents
in this group which are pilocarpine and carbachol (82).
Direct-Acting Cholinergic Drugs

CHARACTERISTICS

PILOCARPINE

CARBACHOL

Indications

Open angle glaucoma

Open angle glaucoma

Class

Parasympathomimetic

Parasympathomimetic

Brand Names

Almocorpine,
Pilocar

Esoptocarbachol,
Miostat

Dose

0.5%-4% solution,
instill 2 drops
four to six times
in eye daily

0.75%- 3%
one drop two to
three times daily
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Direct-Acting Cholinergic Drugs

CHARACTERISTICS

(Cont'd)

PILOCARPINE

CARBACHOL

Mechanisms

Increases the rate of elimination of
outflow of aqueous humor (for both)

Local Side

Conjunctival, congestion, irritation,
myopia, and poor night vision (for both)

__§y~t-~mig_~:i._<!_e__________ Na._u$ea, diarrhea, _bradycardia,_ and
excitation (for both)
Inactivation by
Acetyl
Cholinesterase

More prone

Less prone

Activity

Less Active

More Active

Absorption

More· absorbed

Less absorbed

Comments

Drug of choice

Alternative
(79, 82, 84, 85).

There are also other agents from this group which increases
the rate outflow.

These are cholinesterase inhibitors such as

eserine, (Physostigmine), neostigmine demecarium, echothophate
iodide.

The following table lists the characteristics of

those agents.

This table is extracted form U.S. Pharmacist,

i,

April 1979 ( 82).
Other drugs which increase the outflow are sympathetic
amines such as epinephrine and phenylephrine.

The epinephrine

brand names are Adrenaline, Epifrin, and Epitrate.

The solution

concentration is 1%-2% and is applied twice or thrice daily.
The other drug is phenylephrine for which the solutions concentration is 10%.

The sympathetic drugs will increase the outflow
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and reduce the pressure of aqueous humor (82).
The second class which reduces the rate of aqueous humor
production consists of sympathetic and carbonic anhydrase
inhibitors.

Carbonic anhydrase inhibitors include several

drugs, but the one most commonly used is acetazolamide (Diamox).

The usual adult dose is 250mg four times a day.

The

major side effects of Diamox are gastrointestinal distur-

hypokalemia, hyperuricemia, acidosis and kidney stones.
Diamox is a mild diuretic which reduces the production of
aqueous humor, not from the diuretic effect but by blocking
the ocular carbonic anhydrase.

Hyperosmotic agents such as

mannitol, urea, glycerol, and isosorbid are used to reduce the
ocular pressure by increasing the osmolality of the blood
relative to the fluid of the eye.

The result of that is that

they create an osmotic gradient between the two compartments.
The most common one used is mannitol·which is used at lgmjkg
intravenously over 30 to 45 minutes.

The major side effects

are circulatory overload, edema, cellular dehydration, urinary
retention and electrolyte imbalance.

They are used especially

in preoperative management of acute closed angle glaucome
( 82' 83' 85).

Cholinesterase Inhibitors

PHYSOSTIGMINE (ESERINE)

. _NEOSTIGMINE

DEMECARIUM BROMIDE

Dosage

0.25% to 0.%, one drop
to two drops, three
times daily

5% solution,
one to two drops
every 4-6 hours

0.125% or 0.25%,
one to two drops

Duration of Action

12-30 hours

6-24 hours

1-7 days

Vehicle

water

water

water

Stability

months

weeks

months
J-l

c..v

Strength of
increased outflow

+

Class

Cholinesterase Inhibitors (all)

Indications

Open Angle Glaucoma

Mechanism

Increases the rate of outflow of the aqueous humor 1(all)

Local Side Effects

Pupillary and accommodative spasm, twitching of the: eyelids, pigmentary
changes in the iris, cataracts, conjunctival thick~:ning, refractive changes

Systemic Side
Effects

Nausea, diarrhea, bradycardia, sweating, and central nervous system
excitation (79). (for all)
'

'Ill·

+

+

~

(all)

I

!

il
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Instructions to the Pharmacist

1.

There are many drugs which may induce glaucoma, or
are contraindicated fo~ a patient with glaucoma.
-

A.

Nitroglycerin should not be used in a patient
with glaucoma, because nitroglycerin which is
used· in angina will increase intraocular pressure.

B.

Beta blocking agents such as inderal sometimes
reduce intraocular pressure.

C.

Oral contraceptives may induce glaucoma.

D.

Corticosteroids will increase the intraocular
pressure of the eye.

E.

There is a misconception that systemic anticholingergics aggravates or induce open angle g~aucoma,
but in a patient with abnormal narrow angle
glaucoma this may be true.

2.

Therapy is started by using the smallest dose of
pilocarpine that will control the pressure of the eyes
and increase the dose if there is no, or an inadequate,
response. If the patient is unable to tolerate
pilocarpine, the alternative is carbachol.

3.

Epinephrine in some patients may be used to initiate
therapy.

4.

A combination of drugs may be used depending on the
response of the patient.

5.

Carbonic anhydrase inhibitors are available in two
forms; normal form and sustained released.

6.

Combinations wh1ch are recommended are usually from
a different class, and have a different mechanism.

7.

Monitor the patient closely.

8.

Treatment of closed angle glaucoma is surgery.

"
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Patient Instructions

1.

It is recommended that the person above 40 years of
age should visit the physician and have a routine
examination of his eyes, because there is a type of
glaucoma which is asymptomatic (silent).

2.

Carefully follow the directions which your doctor
recommended to you, and follow the treatment. Report
_______________a_!ly_§_id~_~ff~cts _tQ you_r doc_tor_. _______ .
3.

Open angle glaucoma is considered a chronic disease
and there is no cure for this kind of glaucoma. You
must use your medication all of your life.

4.

If you have more than one kind of eye drops, it is
recommended to give each drop the time to be absorbed
by applying the first drops, and then waiting 10 to
15 minutes before applying the other ones.

5.

Ask your pharmacist or your doctor about any medication which you use other than your eye drops. It
may be contraindicated.

6.

Remember that if you do not use your medication as
recommended the pressure of your eye will rise and
could lead to blindness (82, 85, 86).

CONCLUSION
For the Pharmacist:

It is also true that you are

facing a lot of people every day and your time is limited,
but try to be helpful in your field and your responsibility
as a consultant about the medication.

Be sure that you can

give the patient the correct doses and the correct medication, and give'the patient the best instructions or advice.·
Your good communication with the physician will increase the
level of the job you are doing and the level of treatment.
For the Patient:

It is also too often true that a

doctor, especially in an Outpatient Clinic in any hospital,
has a limited amount of time to spend with you.

Therefore,

to spend the time wisely and to understand carefully the
instructions from your doctor will help you increase the
chance for your recovery.

If you are confused or not sure,

do not be shy, and do not be afraid-to ask again.
cooperative with your physician and the pharmacist.

Be
All of

them want to help you to understand your disease state and
medications.
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